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Jyothi Mahadevan 
THE ROLE OF CFP1 IN MURINE EMBRYONIC STEM CELL FUNCTION AND LIVER 
REGENERATION 
 
CXXC finger protein 1 (Cfp1), a component of the Set1 histone methyltransferase 
complex, is a critical epigenetic regulator of both histone and cytosine methylation. 
Murine embryos lacking Cfp1 are unable to gastrulate and Cfp1-null embryonic stem (ES) 
cells fail to undergo cellular differentiation in vitro. However, expression of wild type 
Cfp1 in Cfp1-null ES cells rescues differentiation capacity, suggesting that dynamic 
epigenetic changes occurring during lineage specification require Cfp1. The domain 
structure of Cfp1 consists of a DNA binding CXXC domain and an N-terminal plant 
homeodomain (PHD). PHDs are frequently observed in chromatin remodeling proteins, 
functioning as reader modules for histone marks. However, the histone binding 
properties and underlying functional significance of Cfp1 PHD are largely unknown. My 
research revealed that Cfp1 PHD directly and specifically binds to histone 
H3K4me1/me2/me3 marks. A point mutation that abolishes binding to methylated H3K4 
(W49A) does not affect rescue of cellular differentiation, but, point mutations that 
abolish both methylated H3K4 (W49A) and DNA (C169A) binding result in defective in 
vitro differentiation, indicating that PHD and CXXC exhibit redundant functions. 
 
The mammalian liver has the unique ability to regenerate following injury. Previous 
studies indicated that Cfp1 is essential for hematopoiesis in zebrafish and mice. I 
hypothesized that Cfp1 additionally plays a role in liver development and regeneration. 
To understand the importance of Cfp1 in liver development and regeneration, I generated 
a mouse line lacking Cfp1 specifically in the liver (Cfp1fl/fl Alb-Cre+). Around 40% of 
these mice display a wasting phenotype and die within a year. Livers of these mice have 
altered global H3K4me3 levels and often exhibit regenerative nodules. Most importantly, 
livers of these mice display an impaired regenerative response following partial 
hepatectomy. Collectively, these findings establish Cfp1 as an epigenetic regulator 
essential for ES cell function and liver homeostasis and regeneration. 
 
David G. Skalnik, Ph.D., Chair
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Introduction 
 
1. Fundamentals of Epigenetics 
Almost every cell of a living organism contains identical genetic content, yet performs 
distinct functions. One of the ways this is made possible is by “epigenetic changes” in 
gene expression without involving changes to the underlying DNA sequence. These 
changes are heritable, self-perpetuating and reversible [1] and are mediated by processes 
that regulate the chromatin landscape, such as DNA methylation and histone 
modifications. The complexities of gene regulation, aging, cellular differentiation, cancer 
and other diseases can be better appreciated with an in-depth knowledge of their 
underlying epigenetic mechanisms. 
 
2. Structure of chromatin 
The eukaryotic genome is packaged into a compact form called chromatin to be 
accommodated into the nuclei of cells. Chromatin is composed of fundamental subunits 
called nucleosomes. Each nucleosome is comprised of 146 base pairs of genomic DNA 
wrapped around an octameric core consisting of two molecules each of histone protein 
H2A, H2B, H3 and H4. Core particles are connected by ~80 base pair long stretches of 
linker DNA. Unlike other histone proteins that form the core, H1 functions as a linker 
connects the exit/entry of the DNA strand on the nucleosome. Nucleosomes along with 
20-60 base pairs of DNA form a 10 nm “beads on a string” structure [2]. Further, 
chromatin is condensed into 30 nm chromatin fibers consisting of chains of nucleosomes. 
These chromatin fibers undergo higher order condensation with the help of the linker H1 
histone, ultimately leading to chromosome formation. 
 
Chromatin is territorially divided into heterochromatin and euchromatin on the basis of 
states of compaction and transcriptional potential. Heterochromatin includes 
transcriptionally silent regions that are densely packaged and stained intensely, when 
subjected to dyes that bind DNA. These regions remain condensed throughout the cell 
cycle. Heterochromatin is further subdivided into constitutive and facultative 
heterochromatin. Constitutive heterochromatin is always compact, gene-deficient, 
repetitive and fulfills structural roles such as telomeres and centromeres. On the other 
2 
hand, facultative heterochromatin comprises of condensed, transcriptionally silent 
regions that can reversibly de-condense and allow transcription to occur on receiving 
suitable developmental signals. Heterochromatin is characterized by DNA 
hypermethylation, histone hypoacetylation and methylation of histone H3 at lysine 9 and 
lysine 27 in higher eukaryotes. 
 
Euchromatin consists of loosely packaged regions of chromatin that stain lightly with 
DNA-binding dyes. This region is concentrated with genes and is often transcriptionally 
accessible. Euchromatin regions undergo cycles of condensation and de-condensation at 
various stages of cell cycle. These regions show hypomethylation of DNA along with a 
predominance of histone acetylation and trimethylation of H3K4, H3K36 and H3K79. 
 
3. DNA cytosine methylation 
DNA cytosine methylation involves the covalent transfer of a methyl group to the C-5 
position of the cytosine ring of DNA by enzymes known as DNA methyltransferases 
(DNMTs). It is a heritable epigenetic mark associated with gene repression and plays a 
crucial role in X-inactivation, genomic imprinting and genome stabilization. DNA 
methylation is also essential for the transcriptional silencing of transposons and 
retroviruses that have accumulated in the mammalian genome [3]. Methylation of 
cytosine residues of DNA generally occurs in a symmetric CpG dinucleotide context [4]. 
The occurrence of CpG in the vertebrate genome is relatively rare (1/5th of the expected 
frequency) [5]. Unmethylated cytosine can undergo spontaneous deamination into uracil 
which is easily recognized as an inappropriate nucleotide and repaired by uracil-DNA 
glycosylase (UDG) [6]. On the other hand, methylated cytosines undergo spontaneous 
deamination to form thymidine thereby mutating CpG to TpG dinucleotides upon 
replication of DNA. This mutation is not easily recognized by the DNA excision repair 
enzymes thymine DNA glycosylase (TDG) or methyl-CpG-binding protein 4 (MBD4) and 
this results in an overall loss of CpG dinucleotide. This explains the relatively rare 
occurrence of the CpG dinucleotide in the vertebrate genome. However, the CpG-
deficient genome is punctuated by CpG islands (CGIs) that are approximately 1000 base 
pair long, have an elevated G-C base composition, are rich in CpG dinucleotides and show 
a frequent absence of DNA methylation [7]. The CGIs have been shown to be functionally 
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important as sites for transcription initiation. Approximately 70% of the annotated gene 
promoters contain CGIs and about half of all CGIs track with promoters of annotated 
genes [7, 8]. 
 
Mammals express three major forms of DNA methyltransferases, DNMT1, DNMT3a and 
DNMT3b. DNMT1, is the first identified and most ubiquitous DNMT enzyme, that 
functions by preferentially methylating hemi-methylated DNA and is required for 
inheriting the pre-existing DNA methylation patterns from parent DNA strands to newly 
synthesized daughter DNA strands [9]. DNMT1 is therefore required for maintenance of 
methylation patterns following DNA replication. DNMT 3a and 3b are expressed highly in 
developmental stages. They have a preference for unmethylated CpG dinucleotides and 
are involved in de novo methylation during development [3, 10]. However, current 
research suggests that DNMT1 may be required for de novo methylation of genomic DNA 
[11] and that DNMT 3a and 3b might be required for maintenance of DNA methylation 
[12, 13]. 
 
The code of DNA methylation is interpreted partly by methyl-CpG binding proteins 
(MBDs). These proteins associate with histone modifiers to establish transcriptionally 
silent chromatin domains. MeCP2 is one such MBD that associates with methylated DNA 
to recruit histone deacetylase (HDAC) and repress transcription in a methylation-
dependent manner [14, 15]. This is suggestive of the inter-relationships between DNA 
methylation-induced transcriptional silencing and histone modifications. 
 
4. Posttranslational modifications of histones (PTMs) 
Core histone proteins consist of globular carboxy-terminal domain that constitute the 
bead-like structure of the nucleosome and flexible amino- terminal tails protruding 
outward from the nucleosome. These tail domains provide a signaling platform for 
interaction with other proteins/protein complexes that function to remodel chromatin 
[16]. Histone tail domains undergo a number of PTMs including acetylation, 
ubiquitylation, sumoylation, phosphorylation and methylation. Several combinations of 
modifications can exist on single histones or single nucleosomes, that result in 
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establishing local and global patterns of chromatin marks thereby specifying unique 
downstream activities [17]. 
 
a. Acetylation 
Histone acetylation involves the transfer of acetyl groups from acetyl-coenzyme A (acetyl-
coA) onto the ε-amino groups of conserved lysine residues, catalyzed by histone 
acetyltransferases (HATs). Histone acetylation is the most extensively studied histone 
modification and is associated with transcriptionally permissible chromatin. Acetylation 
changes the overall charge on histone tails from positive to neutral. This causes a 
reduction in the affinity of N-terminal histone tail domains to the negatively charged DNA 
resulting in an increase in accessibility of DNA to transcription factors [18]. Thus, 
acetylation of histones results in increased expression of genes due to transcriptional 
activation [16, 19, 20]. 
 
The conserved transcriptional regulator Gcn5 was the first protein found to have histone 
acetyltransferase activity. Gcn5 and the partly homologous PCAF commonly modify lysine 
14 of histone H3 and are known to be associated with co-activators or adaptors in multi-
subunit complexes. The Gcn5 containing SAGA (Spt-Ada-Gcn5-acetyltransferase) 
complex is composed of 19 or more subunits in yeast [21]. This complex consists of a 
large number of co-activators that preferentially modify H3 and H2A [16, 19]. However, 
the core acetyltransferase activity of the SAGA complex is contained in the Gcn5 subunit 
[22]. There are several families of acetyltransferases including the GNAT (Gcn5-related 
N-acetyltransferases) superfamily that includes Gcn5, PCAF, Elp3 and Hat1; the 
p300/CBP HAT family that share sequence homology with GNATs and act as 
transcriptional co-activators; and the MYST family of HATs that derives its name from its 
founding members (MOZ, Ybf2/Sas3, Sas2 and Tip60) [19, 23]. 
 
Another protein with HAT activity, known as TAFI (TATA box associated factor), forms a 
part of the evolutionarily conserved TFIID complex along with TBP (TATA binding 
protein) [24]. TBP recognizes the TATA element found in the core promoter regions of 
many genes and functions to recruit other proteins to initiate gene transcription. This 
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suggests that HAT activity at the core promoter may be important for the interaction of 
transcription factors with nucleosomal DNA [23]. 
 
The reversible histone acetylation mark is removed by enzymes known as histone 
deacetylases (HDACs). HDACs are found in corepressor complexes and function by 
removing acetyl groups from histone tails resulting in condensation of chromatin 
structure. Eighteen different mammalian HDACs have been identified and have been 
placed into four distinct classes based on sequence similarity to yeast HDACs. HDACs 
requiring Zn2+ for deacetylase activity are included in Class I, II and IV. Class I HDACs 
possess sequence similarity to yeast RPD3 and comprise of HDAC1, HDAC2, HDAC3 and 
HDAC8. Class II HDACs are related to yeast HDA1 and are subdivided into class IIa 
(HDAC4, HDAC5, HDAC7 and HDAC9) and subclass IIb (HDAC6 and HDAC10). Class III 
HDACs contains 7 sirtuins which require NAD+ as a cofactor and Class IV contains only 
HDAC 11 [25, 26]. Mammalian Class I HDACs (subtypes 1, 2, 3 and 8) have high 
sequence similarity and are abundantly expressed in mSin3A, NURD/Mi2/NRD and 
CoREST corepressor complexes [27]. HDAC3 associates with and is activated by the 
SMRT and NCoR co-repressors that function along with nuclear hormone receptors to 
regulate gene expression [27, 28]. These examples suggest that HATs and HDACs are two 
counteracting enzyme families that perform the dual functions of regulation of histone 
acetylation and association with DNA binding transcriptional activators to bring about 
chromatin remodeling to facilitate appropriate gene expression. 
 
b. Ubiquitination 
Ubiquitin, a 76 aa protein, is conjugated to substrate proteins in a three step reaction: an 
ATP-dependent activation reaction requiring ubiquitin activating enzyme (E1), followed 
by conjugation via a thioester linkage to a cysteine residue on a ubiquitin-conjugating 
enzyme (E2) and finally, ubiquitin is transferred from the enzyme E2 to a target lysine 
residue of the substrate protein by a ubiquitin-protein isopeptide ligase (E3) [29]. While 
polyubiquitination targets proteins for proteasome-mediated degradation, mono-
ubiquitination occurs on histone H2A and H2B and is a widely studied chromatin 
modification. Occurrence of ubH2A is frequently associated with gene repression while 
ubH2B is mostly associated with transcriptional activation. H2A ubiquitination occurs at 
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lysine 119 through at least two different E3 ubiquitin ligases, Ring 1B and 2A-HUB that 
are associated with transcriptional silencing [30]. ubH2A represses transcription 
initiation and inhibits the deposition of euchromatin-associated markers H3K4me2/me3 
[31]. Ring1B associates with Polycomb Repressive Complex 1 (PRC1). Moreover, ubH2A 
and PRC1 colocalize on the inactive X chromosome in mouse [32] [33]. The other H2A 
ubiquitin ligase, 2A-HUB, associates with the N-CoR/HDAC1/3 complex and represses 
transcription of some chemokine genes [34]. 
 
Monoubiquitination of H2B occurs at lysine 120 in vertebrates (lysine 123 in yeast) by 
two ubiquitin conjugating enzymes, homologous to yeast Rad6 enzyme: HR6A and HR6B 
(hRad6A/hRad6B). RNF20 and RNF40 function as ubiquitin ligases (homologous to yeast 
Bre1) and form a complex with HR6A and HR6B to catalyze H2B monoubiquitination 
[35]. In mammalian cells, RNF20/RNF40 associates with transcriptionally active genes 
[36]. H2B ubiquitination also affects di and tri-methylation of H3K4 and H3K79 [37]. 
Current research suggests that the COMPASS methyltransferase complex requires prior 
ubiquitination of H2B for di and trimethylation of H3K4 [38]. This provides an example 
of a crosstalk between histone ubiquitination and another histone mark, histone 
methylation. 
 
c. Sumoylation 
Sumoylation, like ubiquitination, requires covalent attachment of small ubiquitin like 
molecules to lysine residues on histones via the action of E1, E2 and E3 enzymes [39]. 
Sumoylation occurs on all core histones within chromatin and occurs with high frequency 
at sub-telomeres [40]. It is a mark that functions by antagonizing both lysine acetylation 
and ubiquitination on the same histone tail and is therefore frequently associated with 
transcriptional repression [41]. 
 
d. Phosphorylation 
Phosphorylation (ph) of histones at serine or threonine residues is a dynamic process that 
is regulated by kinases and phosphatases that add and remove this mark respectively. A 
very well studied event is the phosphorylation of the histone variant H2AX, that plays a 
significant role in DNA damage response. This modification occurs at the serine (S) 139 
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of the H2AX variant and is commonly referred to as γH2AX. Phosphorylation of H2AX is 
one of the first events that follow DNA damage and it occurs in the vicinity of the double 
stranded break (DSB). This is followed by the bidirectional spreading of this mark over 
several megabases in the mammalian cells [42, 43]. The wide-spread nature of γH2AX 
around the DSB is thought to be required for the recruitment of DNA damage repair and 
signaling factors for facilitating downstream repair pathways [44, 45]. Phosphorylation of 
serine 1 of histone H4 is mediated by casein kinase II (CKII) in response to genotoxic 
stress induced by exposure to ultraviolet light and methyl methanesulfonate (MMS) [46] 
[47]. 
 
Phosphorylation of histone residues is also linked to transcriptional activation. Regulation 
of epidermal growth factor (EGF)-responsive genes involves phosphorylation of serines 
10 and 28 of H3 and serine 32 of H2B [48, 49]. Occurrence of H3S10ph throughout the 
cell cycle is conserved in eukaryotes and hence H3S10ph has been used as a marker for 
mitotic cells in many studies [50, 51]. Phosphorylation of H3S10, T11 and S28 has been 
associated with Gcn5-dependent H3 acetylation. H3S10ph promotes acetylation of 
H3K14 and facilitates Gcn5-mediated transcriptional activation in vivo [52]. This 
coupling of H3S10ph and H3K14ac is also required for the regulation of gene expression 
during mesoderm formation during embryonic development [53]. Another mark, 
H3S28ph is found to displace the polycomb repressive complexes present at gene 
promoters to induce demethylation and acetylation of the adjacent H3K27 residues at 
these loci [47, 54]. Thus, histone phosphorylation is associated with the regulation of a 
number of varied cellular processes. 
 
e. Methylation 
All the four core histones can undergo methylation at arginine and lysine residues. 
Arginine methylation involves transfer of a methyl group from S-adenosyl methionine to 
a guanidino nitrogen of arginine resulting in the formation of methylarginine. Arginine 
residues can either undergo monomethylation and asymmetric or symmetric 
dimethylation catalyzed by protein arginine methyltransferases (PRMTs). PRMT1 is 
responsible for the bulk of arginine methylation activity and is required for the generation 
of asymmetric H4R3me2a, which functions as a transcriptional activation mark [55]. 
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PRMT4 or CARM1 is a steroid receptor coactivator and is responsible for H3R17me2a and 
H3R26me2a [56]. On the contrary, PRMT5 acts as a strong transcriptional repressor [57, 
58]. 
 
Histone lysine methylation involves the methylation of the ε-amino group of lysine 
residues by utilizing the cofactor S-adenosyl-L-methionine (SAM). The SET domain 
containing proteins form a major group of histone lysine methyltransferases (KMTs). The 
SET domain was initially identified in three epigenetic modifiers in Drosophila: 
Suppressor of variegation 3-9, Enhancer of Zeste and Trithorax and was named after 
these founding members. However, Dot1p is a non-SET domain containing protein that 
methylates H3K79 [59]. 
 
A majority of histone lysine methylation marks occur on lysines (K) K4, K9, K27, K36, 
K79 of H3 and K20 of H4. In addition, these lysine residues can be mono (me1), di (me2) 
or trimethylated (me3). This results in a wide range of functional diversity for each 
methylation site. The sites K4, K36 and K79 of H3 are associated with gene activity 
whereas K9 and K27 are related to transcriptional inactivity. 
 
H3K4 KMTs are conserved from yeast to mammals. In yeast, Set1 is the sole H3K4 
methyltransferase that catalyzes deposition of H3K4me1/me2/me3 [60] whereas 
mammals have six Set1-related proteins: Set1a, Set1b and MLL1, MLL2, MLL3 and MLL4. 
These enzymes require additional subunits for their catalytic activity and hence exist in 
the form of a complex with other proteins. The yeast Set1 is contained in a complex 
called COMPASS (Complex of proteins associated with Set1) along with other subunits 
[61]. All the mammalian H3K4 KMT complexes have common components: Ash2L, 
RbBP5, Wdr5 and Dpy30. In addition to these core components, mammalian Set1a/Set1b 
complexes consist of CFP1 (CXXC1) and Wdr82, MLL1/2 complexes contain MEN1 and 
MLL3/4 complexes contain NCOA6, PA1, PTIP and UTX [62]. 
 
The Set1a and Set1b proteins are the catalytic components of the respective complexes. 
These proteins exhibit 39% overall sequence identity and 56% similarity. The conserved 
RRM domain interacts with Wdr82 while the conserved N-SET domain interacts with 
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CFP1, RbBP5, Ash2 and Wdr5. Set1a/b also show the presence of a divergent central 
domain which exhibits only 29% sequence identity. A number of roles of Set1a and Set1b 
have been uncovered recently. Mammalian Set1a and Set1b are responsible for a majority 
of H3K4me marks [63]. Set1a and Set1b exhibit non-overlapping subnuclear distribution 
with euchromatin domains, suggesting that these enzymes are targeted at distinct genes 
[64]. A Set1a-interacting protein, Wdr82, is required for targeting the Set1A-mediated 
H3K4 trimethylation to transcription start sites by physically associating with the Ser5-
phosphorylated C-terminal domain (CTD) of RNA polymerase II[65] [63]. Human Set1a 
has been implicated in the proliferation of colorectal tumor cells by regulating the Wnt-
signaling target genes [66]. 
 
Set1b, on the other hand, interacts with the leukemogenic Rbm15-Mkl1 fusion protein 
associated with acute megakaryoblastic leukemia (AMKL) [67]. Although both Set1a and 
Set1b have almost identical proteomic profiles, they are essential at distinct stages of 
murine development [68]. Set1a appears to be important for gastrulation whereas Set1b-
lacking embryos, although highly retarded, can gastrulate. Set1a is also required for 
derivation of induced pluripotent stem cells and for the maintenance of the 
transcriptional profile of genes governing cell-fate decisions in pluripotent embryonic 
stem (ES) cells [68]. The euchromatin associated yeast Set1 complex also mediates 
silencing at telomeres and represses RNA polymerase II activity within the rDNA locus 
[69, 70]. 
 
Mammalian MLL1 and MLL2 Drosophila homologs of trithorax (trx) and are involved in 
positive regulation of homeotic gene expression. MLL1 regulates the expression of the 
Hox gene, and is implicated in leukemic pathogenesis [71, 72]. However, MLL1 is 
required for the appropriate H3K4me3 levels of only 5% of the gene promoters that 
display this mark [73]. These genes include developmentally important Hox genes. 
MLL1 is required for the regulation of transcription initiation of a subset of Hox genes by 
RNA polymerase II [73]. MLL2, on the other hand, is essential for H3K4 trimethylation in 
oocytes [74]. The common component of the MLL1/2 complexes, Menin, is required for 
the majority of H3K4 methylation at the Hox loci [73]. Mammalian MLL3/4 is 
homologous to Drosophila trithorax-related (Trr) and functions as a major H3K4
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Figure 1: Many posttranslational modifications occur on N-terminal histone tail 
domains 
After the process of translation, histone proteins undergo several modifications at their N-
terminal tails. Some of these modifications are activating marks whereas others are 
repressive marks. The figure represents the four histone proteins that form the 
nucleosome and the posttranslational modifications (Me: methylation, Ac: Acetylation, 
Ph: Phosphorylation) occurring on specific amino acids. Figure adapted from 
http://www.psych.mpg.de/1496016 
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monomethyltransferase [75]. Other enzymes capable of H3K4 methylation include 
Smyd1, Smyd2, Smyd3 and Set7/9. 
 
H3K4me3 marks concomitantly occur with active transcription whereas H3K4me2 can 
occur at poised or inactive genes [76]. H3K4me3 is widely accepted as a euchromatin 
marker [77, 78]. Monomethylation of H3K4 (H3K4me1) is predominant at the distal 
enhancer regions [79]. 
 
H3K36 methylation is carried out by the Set2 enzyme [80]. Initially, the Set2 enzyme and 
the H3K6 methyation mark were thought to be associated with transcriptional repression 
[80] . However, recent reports suggest that H3K36me3 occurs within the body of active 
genes. Moreover, in Caenorhabditis elegans, exonic regions are enriched with H3K36me3 
as compared to intronic segments within the same gene [81]. Set2 is recruited to 
chromatin via association with RNA polymerase II and is also thought to participate in 
transcription elongation [82]. It might be possible that the Set2 is involved in gene 
activation or repression depending on gene context. 
 
As mentioned earlier, methylation of H3K79 is carried out by the non-SET containing 
enzyme, Dot1 (disruptor of telomeric silencing) [83]. Dot1 preferentially methylates 
H3K79 in the context of nucleosomes rather than core histones [83]. H2B-K123 and 
H3K79 lie in close proximity on the same nucleosome surface [84] and it was recently 
found that monoubiquitination of H2B-K123 was required for H3K79 and H3K4 
methylation [85]. Moreover, H3K79me occurs at actively transcribing regions and is also 
involved in transcriptional elongation [59, 86]. 
 
H3K9me3 is usually associated with transcriptionally inactive chromatin. Methylation of 
H3K9 is catalyzed by several enzymes: SETDB1 (ESET), SUV39H1, SUV39H2, EHMT1 
(GLP) and EHMT2 (G9A). SETDB1, an enzyme highly expressed in ES cells, is required 
for maintaining pluripotency and self-renewal properties of ES cells [87, 88]. SUV39H1 
and SUV39H2 govern H3K9-methylation at pericentromeric heterochromatin and are 
important for mammalian development [89]. On the contrary, EHMT1 and EHMT2 are 
responsible for deposition of H3K9me3 at euchromatic loci [90]. 
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Unlike the existence of several enzymes that catalyze the deposition of H3K9me3, the 
repressive H3K27me mark is established by polycomb repressive complex 2 (PRC2), 
which consists of EZH2, EED, SUZ12 and RbAp46/48 [91]. EZH2 possesses catalytic 
activity, whereas EED performs an adaptor role by connecting the components [92]. 
EZH1 is a sequence homolog of EZH2 and forms the non-canonical EZH1-mediated PRC2 
which complements the function of the canonical EZH2-mediated PRC2 in the deposition 
of H3K27me3 marks [93]. H3K27 methylation has been linked to many key processes 
including genomic imprinting, X-inactivation and silencing of Hox genes [94]. 
 
H4K20 methylation is a major and highly conserved mark found on the N-terminal tail on 
lysine 20 of H4 [95]. Tri-methylation of H4K20 is characteristic of heterochromatic 
regions, whereas H4K20me1/me2 marks play important roles in DNA replication and 
DNA repair processes [96, 97]. Monomethylation of H4K20 is performed by Set8/PR-Set7 
and further di- and tri-methylation is catalyzed by SUV4-20H1 and SUV4-20H2 [98]. The 
dynamic control of histone lysine methylation requires the participation of demethylase 
enzymes that remove methyl groups from lysine residues. The Flavin Adenine 
Dinucleotide (FAD) requiring Lysine specific demethylase I (LSD1) was one of the first 
identified demethylase enzymes [99]. LSD1 requires a chromatin-associated 
transcriptional repressor CoREST and its action specific to H3K4me2 and H3K4me1 
[100]. Another major group of histone lysine demethylases known as Jumonji C domain 
containing histone demethylases (JHDMs) have a characteristic Jumonji C domain [101]. 
Of these enzymes, JHDM1 specifically demethylates H3K36me2/me1 but H3K36me3 
demethylation is catalyzed by JHDM3. On the other hand, H3K9me1/me2 are substrates 
of JHDM2 whereas H3K9me3 mark is demethylated by JHDM3 [102]. The activating 
histone mark H3K4me2/me3 is removed by another group of Jumonji C containing 
enzyme family termed JARID1 [103, 104]. 
 
5. Histone code and its complexity 
Apart from the histone PTMs described in this study, many others including 
crotonylation, butyrylation and propionylation of lysine residues, citrullination and ADP-
ribosylation of arginine residues, and glycosylation of serine and threonine residues have 
also been identified [105]. Some of these modifications are associated with active gene 
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transcription whereas others are related to gene repression. This pattern led to the idea 
that histone modifications could form a “code” that could be recognized by 
transcriptional factors and thereby dictate the transcriptional state of the gene. The 
histone code hypothesis was therefore put forth by Strahl and Allis which states “distinct 
histone modifications, on one or more tails, act sequentially or in combination to form a 
'histone code' that is, read by other proteins to bring about distinct downstream events” 
[106]. 
 
A number of examples of histone crosstalk mechanisms have been described in literature. 
One of the well-studied crosstalk mechanisms is the ability of H3S10ph to stimulate the 
Gcn5-mediated acetylation of H3K14 and synergistically mediate gene transcription [52, 
107]. In mammalian cells, H3S10ph also inhibits methylation of H3K9, a 
heterochromatin mark. This is an example of a ‘cis’ effect established by the 
communication of adjacent modifications in the same histone tail. Of higher interest, is 
the ‘trans’ effect that can occur by cross talk between modifications present on different 
histones either within a single nucleosome or across several nucleosomes [17]. For 
instance, monoubiquitination of H2B is required for methylation of H3K4 by the 
COMPASS complex [108]. Methylation of H4R3 by PRMT1 is inhibited by acetylation of 
H4 at K5, K8, K12 and K16 [17, 109]. Trimethylation of H4K20 at constitutive 
heterochromatin requires prior deposition of H3K9me3 [97]. 
 
Many histone crosstalk mechanisms are mediated by effector proteins that target PTMs. 
Specific recognition of PTMs by effector proteins is required for the recruitment of various 
signaling components, including transcription factors, to chromatin, for the function of 
key processes like gene regulation, DNA replication, DNA repair, formation of 
heterochromatin and chromatin remodeling. The catalytic action of chromatin modifying 
enzymes usually requires additional subunits. One or more of these subunits can 
specifically recognize distinct PTMs and mediate downstream signaling events. Soon after 
the histone code hypothesis was suggested, chromatin signaling components were 
classified into groups such as ‘writers’, ‘erasers’ and readers’ [110, 111]. Writers and 
erasers are proteins involved in deposition and removal of histone modifications 
respectively, and have been discussed in detail in earlier sections. Readers, on the other 
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hand, recognize/read these covalent signals specifically and relay the information to 
downstream players of the chromatin signaling pathway to establish distinct chromatin 
states. 
 
A lot of interest has been generated recently in the study of reader modules because of 
the remarkable specificity and dynamic nature of the interaction of these domains with 
PTMs. These reader modules are known to provide an accessible surface for binding the 
incoming modified histone tail after determining the kind of modification 
(acetylation/methylation) and specificity of state (unmodified/mono/di or tri-
methylation of lysine) [112]. One of the first identified readers is the bromodomain 
(BRD). BRDs are found in many chromatin remodeling complexes including SAGA, 
SWI/SNF, RSC, p300/CBP and TFIID. BRDs, in general, are thought to bind acetylated 
lysine residues and increase the affinity of these enzyme complexes to this mark [113]. 
BRD of Gcn5 that can read the monoacetylation marks on histone lysine residues [114]. 
In this case, Gcn5 can also catalyze acetylation of these residues, suggesting that this 
communication might be responsible for spreading of acetylation marks in chromatin. 
Taf1, the largest subunit of TFIID, consists of two BRDs with which it binds multiple 
acetylated lysines on the H4 tail [115]. Phosphorylated serine residue on H2AX (γH2A) is 
read by the BRCT domain of mediator of DNA damage-checkpoint1 (MDC1) and this 
regulates the repair of DNA double-strand breaks [45]. Moreover, mammalian 14-3-3 
also recognizes H3S10ph and is recruited to c-fos and c-jun nucleosomes upon gene 
activation [116]. 
 
a. Readers of methylated and unmodified histone H3 
Histone H3 can be methylated at either the arginine or lysine positions. The symmetric 
H4R3me2s mark is recognized by the ADD (ATRX, DNMT3, DNMT3L) domain of 
DNMT3a thereby linking this modification to gene inactivation [117]. In contrast, the 
Tudor domain of TDRD3 (Tudor domain containing 3) interacts with H3R17me2a 
H4R3me2a. TDRD3 functions as a transcriptional coactivator and links these 
modifications to gene activity [118]. 
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Readers of methylated lysine residues on histone H3 are particularly well-studied. The N-
terminal chromodomain (CHD) of HP1 (Heterochromatin associated protein1) binds to 
the H3K9 methyltransferase SUV39H1 and is found to read methylated H3K9, the 
product of this enzyme complex [119]. It was found that methylation of H3K9 results in 
creation of a binding site for interaction with HP1, which is suggestive of a role for this 
interaction in the propagation of heterochromatin [120]. Proteins that read methylated 
H3K4 and unmodified H3 show the presence of a characteristic plant homeodomain 
(PHD). However, PHDs are also known to interact with acetylated lysine residues. [121, 
122]. 
The PHD finger consists of 50-80 aa residues and exhibits a zinc-binding motif [123]. 
This relatively small domain, consists of a two strand anti-parallel β-sheet and a C-
terminal α-helix (present in few PHDs) that is stabilized by two zinc atoms scaffolded by 
the signature Cys4-His-Cys3 motif in a cross-brace topology [124]. The PHD of BPTF 
(Bromodomain and PHD domain transcription factor) was one of the first identified 
proteins within the PHD family proteins to read the histone code. BPTF is the largest 
component of the ATP-dependent chromatin remodeling NURF (Nucleosome remodeling 
factor) complex and is associated with actively transcribed genes [125]. The 
bromodomain-proximal PHD specifically recognizes H3K4me3 to stabilize the NURF 
complex at chromatin and improves the efficiency of NURF-catalyzed nucleosome sliding 
and activation of developmentally important gene promoters [126]. The ING family of 
tumor suppressors contains ING2 that plays a pivotal role in the regulation of cell 
replication, DNA repair and apoptosis [127]. ING2 forms a part of the repressive 
mSin3A/HDAC1 complex. Upon induction of DNA damage, ING2 associates with 
H3K4me2/3, recruits the mSin3A/HDAC1 complex to chromatin thereby negatively 
regulating gene transcription [128]. Pygopus 2 (Pygo2) is a downstream component of 
the canonical Wnt pathway in Drosophila. Pygo2 is required for the proper development 
of various tissues [129]. Pygo2 consists of a PHD finger that associates with di and 
trimethylated forms of H3K4 and also facilitates H3K4 methylation by associating with 
Wdr5, an essential and common component of the SET-domain containing histone 
methylase complexes [130]. PHF2, a histone demethylase enzyme belonging to the 
JHDM family, consists of a PHD domain and a Jumonji C-domain. The PHD finger of 
PHF2 specifically recognizes H3K4me3, and this is essential for PHF2-dependent 
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promoter H3K9-demethylation and expression of ribosomal DNA (rDNA) [131]. TAF2 
associates with H3K4me3-enriched nucleosomes via its PHD finger and anchors the 
transcription factor TFIID to chromatin for gene activation [132]. Recombination-
activating gene 2 (RAG2) encodes for the catalytic enzyme that plays a critical role in 
V(D)J recombination, a process that involves the assembly of antigen-receptor genes. 
RAG2 protein consists of a PHD finger that binds H3K4me3 at actively arranging gene 
segments and is necessary for efficient recombination to occur [133, 134]. 
 
A separate subset of PHD fingers recognizes unmodified H3. This suggests that 
unmodified H3 can act as distinct histone marks and be recognized by reader modules. 
The PHD fingers in this group lack an aromatic cage, a characteristic of H3K4me binders 
[124]. It is frequently observed that the interaction between these PHD fingers and 
unmodified H3 is ablated by methylation of H3K4 [124]. BHC80 is a component of the 
lysine-specific histone demethylase (LSD1) that removes H3K4me1/2 marks. BHC80 
associates with unmodified H3, the product of LSD1-mediated enzyme action, and is 
essential for LSD1-mediated gene repression [135]. Auto immune regulator (AIRE) 
consists of two PHD domains (PHD1 and PHD2). The first PHD (PHD1) interacts with 
unmodified H3 and this binding is critical for appropriate expression of tissue- specific 
antigens in the thymus [136]. DNMT3L stimulates the DNA-methyltransferase activity of 
DNMT3a to achieve a repressive chromatin state. DNMT3L recognizes unmodified H3 
and induces de-novo methylation by recruitment of DNMT3A [137]. 
 
6. PHD fingers in human diseases 
PHD finger-containing proteins are associated with numerous human diseases including 
cancers and immunodeficiency disorders. 
 
Loss or mutation of the ING family members, attributed with tumor suppressor roles, 
have been reported in a number of human cancers including esophageal squamous cell 
carcinoma, gastric cancer and breast cancer [138, 139]. The exact mechanism of 
occurrence of these cancers is unknown, however ING family of proteins are linked to 
critical functions such as cell cycle control, DNA repair, apoptosis and senescence [127]. 
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APECED (Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy) is an 
autosomal recessive disease associated with a number of autoimmune abnormalities 
including diabetes, thyroid disease and failure of adrenocorticoids and gonads [140]. 
Some of the APECED-linked mutations are found within the PHD domains of AIRE. 
Missense mutations in PHD1 have been found to destabilize the structure of AIRE-PHD1, 
resulting in loss of binding with unmodified H3 and in turn affecting gene transcription 
[136, 141]. Mutations in the Rag2 PHD finger have been found in patients with severe 
combined immunodeficiency (SCID) syndrome [142] . These patients completely lack B 
and T lymphocytes and suffer from severe immunological abnormalities [142, 143]. 
Mutations disrupting the aromatic cage of RAG2 PHD inhibit its binding to H3K4me3 and 
pathologically result in a milder form of SCID called Omenn’s Syndrome. This occurs 
chiefly because of an impairment in V(D)J recombination [144, 145]. 
 
The involvement of PHD finger-containing proteins in a spectrum of human diseases, 
makes the idea of using PHDs as drug targets, attractive. Research in the future should be 
aimed at developing gene-therapeutic approaches to re-establish the disrupted gene 
regulation pathways and thereby treating the underlying diseases that occur due to 
aberrant PHD domain function. 
 
7. Role of chromatin in embryonic development and ES cell differentiation 
Embryonic development involves the generation of a multitude of different cell types 
each with distinct gene-expression patterns. Each of these cells originates from a single 
totipotent cell and retains its genetic information. Such a wide disparity between genetic 
material and phenotypic features can be attributed to epigenetic changes occurring 
during the process of embryonic development. Several developmental defects are 
observed when epigenetic modifications are blocked. For instance, targeted disruption of 
DNMT1 (maintenance DNA methylation) or DNMT3a and DNMT3b (de novo DNA 
methylation) results in embryonic lethality [10, 146]. Also, depletion of G9a, an enzyme 
responsible for H3K9me, results in early embryonic lethality [90]. 
 
DNA methylation plays a significant role in the process of genomic imprinting. It is an 
epigenetic mechanism in which genes are expressed in a parent-of-origin specific manner. 
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In mice, maternal and paternal chromosomes undergo a wave of demethylation after 
zygote formation [147, 148]. This occurs as a result of a passive mechanism that removes 
most, but not all of the methylation marks inherited from the gametes and is thought to 
be completed by the blastocyst stage [147, 148]. However, maternal and paternal 
imprints are preserved. Further, after implantation of the embryo, de novo methylation 
establishes embryonic DNA methylation patterns beginning from the inner cell mass of 
the blastocyst [147-149]. 
 
Dosage compensation in mammalian cells occurs by the silencing of one X-chromosome 
in female cells. Silencing of the X-chromosome is initiated early in the developmental 
process and involves the coating of the X-chromosome with the X-inactive specific 
transcript (Xist). This process requires the regulated action of several repressive changes 
including DNA methylation, inactivating histone modifications and recruitment of the 
polycomb group proteins to establish stable repression of a single X-chromosome [150, 
151]. 
 
Embryonic stem cell differentiation is a very useful model to study chromatin changes 
occurring during this process. Embryonic stem cells are obtained from the inner cell mass 
of the embryo at the blastocyst stage. These cells can be cultured indefinitely in vitro and 
can be induced to differentiate through the formation of non-adherent spheroidal cell 
aggregates known as embryoid bodies. ES cells are often maintained in the presence of 
Leukemia Inhibitory Factor (LIF) to prevent spontaneous differentiation in culture. 
Removal of LIF from ES cell growth media pushes the cells towards differentiation. 
However, these cells do retain their proliferative potential [152]. 
 
ES cells exhibit an open chromatin configuration. Undifferentiated human ES cells 
possess less heterochromatin than differentiated ES cells as observed by electron 
microscopy [153]. Major architectural proteins such as HP1 and linker histone H1 display 
hyperdynamic plasticity in binding chromatin in these cells [154]. Undifferentiated ES 
cells exhibit widespread active chromatin domains consisting of activating histone marks 
including H3K4me and H3K9ac; and hypomethylated DNA.[4, 155-157]. 
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Table 1: Epigenetic changes resulting in transcriptionally active chromatin 
Epigenetic modification Writers Readers 
Histone acetylation HATs: GNAT, p300/CBP, 
MYST families, TAFI 
Bromodomain  
H2B ubiquitination HR6A, HR6B  
H3S10, H3S28 
phosphorylation 
Kinases H3S10ph: 14-3-3 
Arginine methylation H4R3me2a: PRMT1 
H3R17me2a, 
H3R26me2a: PRMT4  
H4R3me2a, H3R17me2a: 
TDRD3 
Histone methylation H3K4me: Set1a, Set1b, 
MLL1-4 
Smyd1-3, Set7/9 
H3K36me: Set2  
H3K79me: Dot1 
H3K4me3: BPTF, ING2, 
Pygo2, Wdr5, PHF2, TAF2, 
RAG2 
Histone demethylation H3K9me1/me2: JHDM2 
H3K9me3: JHDM3 
 
 
Table 2: Epigenetic changes resulting in transcriptionally inactive chromatin 
Epigenetic modification Writers Readers 
DNA methylation DNMT1. DNMT3a, 
DNMT3b 
MBDs 
Histone deacetylation HDACs: Class I-IV  
H2A ubiquitination Ring 1B , 2A-HUB  
Histone methylation H3K9me: SETDB1 (ESET), 
SUV39H1, SUV39H2, 
EHMT1 (GLP), EHMT2 
(G9A) 
H3K27me: PRC2 
H4K20me: Set8/PR-Set7  
SUV4-20H1 and SUV4-
20H2  
H3K9me: HP1 
Histone demethylation H3K4me1/me2: LSD1 
H3K4me2/me3: JARID1 
H3K36me1/me2: JHDM1 
H3K36me3: JHDM3 
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ES cell differentiation is a highly dynamic event accompanied by global changes in the 
chromatin architecture resulting in a gradual change from an open and active to a more 
compacted and inactive state. Heterochromatin domains become more abundant, which 
is supported by the observation that well-differentiated ES cells exhibit an overall 
increase in repressive chromatin modifications such as H3K9me2 and H3K37me3 [153, 
158, 159]. Moreover, HDAC activity, associated with gene repression, is required for 
embryonic stem cell differentiation [159]. 
 
8. CXXC finger protein 1 (CFP1) 
Human CFP1, encoded by the CXXC1 gene, is a component of the euchromatin-specific 
Set1a and Set1b methyltransferase complexes that deposit H3K4me marks [64, 160, 
161]. CFP1 homologues are found in other species such as S. cerevisiae, S. pombe, D. 
melanogaster, C.elegans, X. laevis and M. musculus.  
 
CFP1 (656aa) is transcriptional activator that is ubiquitously expressed in all tissue-types 
[160]. The domain structure of CFP1 consists of a highly conserved, cysteine rich, CXXC 
domain that specifically binds unmethylated CpGs [160]. The consensus DNA sequence 
for CFP1 binding is (A/C)CpG(A/C) and methylation of cytosine residues within CpGs 
abolishes CFP1 interaction [162]. It was found that unmethylated CpG are sufficient to 
recruit CFP1 and thereby establish domains of H3K4me3 [163]. CXXC domains are also 
found in other chromatin-associating proteins including DNMT1, MBD1 and MLL2 [164-
166]. CXXC domain is not conserved in S. cerevisiae, S. pombe and C.elegans, and these 
organisms lack cytosine methylation, suggesting that CXXC domain may play a role in 
cytosine methylation. 
 
CFP1 also consists of a 47 aa long, N-terminal PHD domain that shows the presence of 
the conserved Cys4-His-Cys3 motif. A proteome-wide screen of proteins containing PHD 
fingers in S. cerevisiae established that the yeast CFP1 homolog, Spp1 interacts with 
H3K3me2/me3 [167]. It is currently unknown if human CFP1 PHD interacts with 
histones. 
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Moreover, CFP1 also consists of a cysteine rich Set1 interaction domain (SID) that 
mediates interaction of CFP1 with the Set1a and Set1b complexes [168]. The acidic 
domain is rich in aspartate and glutamate residues and is important for transcriptional 
activation [169]. On the contrary, the basic domain is enriched with lysine and arginine 
residues. Coiled coil domains facilitate homo- or hetero-dimerization of proteins and are 
frequently found in DNA binding proteins [160]. The precise function of the basic and 
coiled-coil domains in CFP1 is unknown. HEAT (Huntingtin, elongation factor 3 (EF3), 
protein phosphatase 2A (PP2A), and the yeast kinase TOR1) domain is a solenoid protein 
domain known to facilitate protein-protein interactions in other proteins (Figure 2) [170, 
171]. 
 
CFP1 is essential for vertebrate development as targeted disruption of CXXC1 gene results 
in peri-implantation lethality (~4.5-6.5 days post coitum) in murine embryos [172]. This 
correlates temporally with a global change in DNA methylation patterns [149]. Antisense 
targeting of CFP1 in zebrafish embryos resultd in embryo runting, cardiac edema and a 
failure of primitive hematopoiesis [173]. It was observed that shRNA-mediated 
knockdown of CFP1 inhibits the growth, differentiation and viability of PLB-985 human 
myeloid cell line [174]. Due to early death of CXXC1−/− embryos, studies on the function 
of CFP1 during mammalian post-gastrulation development and homeostasis could not be 
performed. However, this was made possible by developing mice that are homozygous for 
the conditional CXXC1 allele and carry the Mx1-Cre recombinase transgene. On induction 
of Mx1-Cre recombinase with poly-IC, deletion of CFP1 occurred in all hematopoietic cell 
lineages and the liver [175]. Depletion of CFP1 in adult mice results in death within 9-13 
days and reduced bone-marrow cellularity and mature peripheral blood cells. However, 
the Lin−Sca-1+c-Kit+ (LSK) population of cells that is enriched for hematopoietic stem 
cells and multipotential progenitor cells in the bone marrow remain unaffected and 
continue to proliferate in the absence of CFP1 during the two week time period. 
However, no pathology was observed in the quiescent liver tissue during this time period 
[176]. As CFP1 is ubiquitously expressed in all adult tissues including liver, CFP1 may be 
important for long-term liver homeostasis, an assessment of which is limited in this 
model system due to the short time interval (2 weeks) between gene deletion and death 
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Figure 2: Domain structure of CFP1 
This schematic representation depicts the various conserved domains of CFP1. The amino 
acid position of each domain within the primary sequence is denoted under the figure. 
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due to hematopoietic failure. These studies collectively suggest that CFP1 plays a critical 
role in embryonic as well as post-gastrulation development. 
 
To obtain further insight into CFP1 function, ES cells were isolated from the inner cell 
mass of blastocysts lacking the CXXC1 gene (CXXC1−/−) and heterozygous blastocysts 
(CXXC1+/−) [177]. Heterozygous CXXC1+/− ES cells display a phenotype similar to wild 
type (CXXC1+/+) ES cells. However, CXXC1−/− ES cells display a wide variety of defects. 
These cells have increased population doubling time due to a 3-fold increase in apoptosis 
but show normal cell-cycle distribution [177]. CXXC1−/− ES cells fail to differentiate 
upon removal of LIF from the growth medium. They form embryoid bodies but are 
unable to form the characteristic endodermal outgrowths and fail to induce lineage and 
developmental markers and fail to down-regulate the expression of markers of stem cells, 
Oct4 and alkaline phosphatase. A 60-80% defect in global cytosine methylation levels is 
observed in CXXC1−/− ES cells [177]. These cells exhibit a ~30% reduction in DNA 
methyltransferase activity towards a hemi-methylated oligonucleotide substrate but 
normal activity towards an unmethylated substrate. This suggests that CXXC1−/− ES cells 
have a deficiency in maintenance methyltransferase activity but normal de novo 
methylation activity [177]. CXXC1−/− ES cells also displayed a 15% decrease in global 
protein synthesis [178]. ES cells lacking CFP1 display altered histone methylation levels. 
A global increase in H3K4me2 levels (~43%) and reduction in H3K9me2 levels are 
observed in CXXC1−/− cells under normal conditions [161]. On induction of 
differentiation, wild type ES cells showed a gradual decline in H3K4me2 levels. However 
ES cells lacking CFP1 exhibit a steady 4-fold increase in H3K4me3, six days after 
induction of differentiation by removal of LIF [159]. The observation of increased H3K4 
methylation levels in CXXC1−/− ES cells suggests that CFP1 restricts the activity of the 
Set1 H3K4 methyltransferase complexes. This was confirmed by confocal 
immunofluorescence. Wild type ES cells show almost no overlap between DAPI-bright 
(heterochromatin) regions and endogenous euchromatin-specific Set1a. However, in the 
absence of CFP1, ~25% of Set1a is detected inappropriately within DAPI-bright 
heterochromatin. Stable re-expression of CFP1 into CXXC1−/− ES cells results in the 
appropriate exclusion of Set1a from DAPI-bright heterochromatin. Similar results were 
obtained for H3K4me3, a product of the Set1 complex [179]. 
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Genome-wide ChIP-seq analysis indicates that CFP1 was found along with H3K4me3 at 
~80% of CGIs in mouse brain and siRNA-mediated knockdown of CFP1 in NIH-3T3 cells 
results in a drop of H3K4me3 levels at these sites [163]. This suggests that CFP1 may 
tether the Set1 complex to CGIs by binding to unmethylated CpGs. In the absence of 
CFP1 and the resultant lack of tethering function, Set1 may diffuse to inappropriate 
genomic locations. 
 
The defects found in CXXC1−/− ES cells can be rescued by stable expression of CFP1 in 
CXXC1−/− ES cells. This feature was used to probe the structure-function relationships of 
CFP1. These studies demonstrated that expression of either the amino terminal half (1-
367aa) or the carboxy terminal half (361-656aa) of CFP1 was sufficient to rescue defects 
in global cytosine methylation levels and in vitro differentiation. Introduction of a point 
mutation (C169A) within the amino terminal half (1-367aa) ablates the DNA binding 
function and a point mutation (C375A) within the carboxy-terminal half inhibits binding 
of CFP1 with the Set1 enzyme [162, 168]. Introduction of the DNA binding mutation within 
1-367 aa or the Set1 interaction mutation within 361-656 aa of CFP1, fails to rescue 
cytosine methylation and in vitro differentiation defects. Introduction of either of these 
mutations within full-length CFP1 cDNA had no adverse effect on rescue activity. This 
suggests that neither of these domains is required for rescue activity. However, introduction 
of both of these mutations within full length CFP1 cDNA results in loss of rescue function. 
Therefore, retention of either the CXXC or the SID domain of CFP1 is required for the rescue 
of cytosine methylation and in vitro differentiation [180]. However, appropriate subnuclear 
localization of Set1 and H3K4me3 to euchromatin requires both the CXXC and SID domains 
of CFP1 [179]. 
 
Genome wide analysis of H3K4me3 levels in CXXC1−/− ES cells revealed that this 
chromatin mark was reduced at approximately one-half of the CGI-rich gene promoters. 
Moreover, absence of CFP1 also resulted in ectopic H3K4me3 peaks at regulatory regions 
devoid of CGIs or transcription start sites. Both of these defects could be rescued by the 
stable expression of full length CFP1 in CXXC1−/− ES cells [181]. Another interesting 
observation was that the DNA binding mutant form of full-length CFP1 could rescue 
appropriate H3K4me3 levels at most CGIs. However, this mutant could not rescue the 
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inappropriate occurrence of ectopic H3K4me3 peaks outside of CGIs. These results 
suggest that DNA binding domain is not necessary for the targeting of H3K4me3 to CGIs 
and that some other domain may perform this function [181]. As mentioned earlier, the 
yeast CFP1 homolog Spp1 binds H3K4me2/me3 marks on chromatin via its PHD finger. It 
is possible that human CFP1 PHD binds histones in a similar way and regulates Set1 
targeting. 
 
9. Liver homeostasis and regeneration 
The mammalian liver is a vital organ required for several important metabolic functions. 
It receives a majority of blood from the small and large intestine through the portal vein 
and functions to detoxify harmful chemicals. The liver is responsible for the storage of 
carbohydrates in the form of glycogen and processes nutrients absorbed by the intestines 
and converts them to nutrient forms that can be used by the body. The liver produces 
secreted proteins like albumin and coagulation factors. The liver also synthesizes bile for 
emulsification and absorption of fat [182]. Moreover, the circadian clock system in the 
liver plays a critical role in regulation of liver function and homeostasis [183]. 
 
In mice, embryonic liver originates from the endoderm germ layer that is established 
during gastrulation. The initial morphological sign of the embryonic liver is observed 
adjacent to the developing heart at embryonic day of gestation 9 (e9.0). At e9.5, hepatic 
endoderm cells, known as hepatoblasts, are involved in formation of the liver bud. 
Between days e10-e15, the liver bud undergoes extensive growth, formation of blood 
vessels and colonization by hematopoietic cells making it the chief hematopoietic organ 
at this stage. Hepatoblasts have dual-potential, in that they can either result in the 
formation of biliary epithelial cells that line the intra-hepatic bile ducts or form mature 
functional hepatocytes. This gradual process begins at e13 and continues until after birth 
to ultimately result in a characteristic hepatic architecture to the liver [184, 185]. 
 
In the mature liver, a majority of functions are performed by the parenchymal cells or 
hepatocytes that constitute ~80% of the liver mass. Fully differentiated hepatocytes are 
quiescent and rarely undergo cell division in an adult animal. Therefore, active chromatin 
remodeling is unlikely to occur in adult liver tissue. The remaining 20% of the hepatic 
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cells are non-parenchymal and include endothelial cells that line hepatic blood vessels, 
lymphocytes that provide innate immunity against infection, Kupffer cells that 
phagocytose foreign particles and produce cytokines and stellate cells that produce 
factors leading to hepatic fibrosis in response to injury [186]. 
 
The most distinctive feature of the liver is its ability to regenerate in response to chemical 
or physical injuries. This property of the liver is widely studied in rodents by performing a 
surgical procedure called ‘partial hepatectomy’ that involves the removal of two-thirds of 
the liver [187]. In response to this injury, the residual hepatocytes re-enter the cell cycle 
and undergo one round of DNA synthesis which peaks at ~36 hours in the murine liver. 
A second, smaller wave of DNA synthesis occurs to re-establish the original number of 
hepatocytes. This is followed by a wave of apoptosis to precisely regulate the regenerative 
response [182, 188]. This process is thought to be completed in 7 days after surgery in 
mice. Thus, the process of liver regeneration is thought to be purely mitotic, without the 
involvement of liver-stem or progenitor cells. It is a compensatory mechanism to 
replenish the lost mass to restore proper functioning of the liver. Once the original mass 
of the liver is restored, the mitotic response of the remnant hepatocytes comes to a halt 
[186]. It is very likely that the dynamic process of liver regeneration is accompanied by 
active changes in chromatin structure to facilitate regulation of liver regeneration. 
 
A number of growth factors and cytokines participate in the regulation of liver 
regeneration. For instance, growth factors that are required include insulin, glucagons, 
hepatocyte growth factor (HGF), epidermal growth factor (EGF) and transforming 
growth factors (TGF) and important cytokines include tumor necrosis factor-α (TNF-α) 
and interleukin-6 (IL6) [186, 189]. Besides these, regulation of liver regeneration also 
requires the interplay of a number of transcription factors. Furthermore, optimal 
telomerase activity is required for efficient liver regenerative response as cells with 
shortened telomeres are unable to replicate efficiently [190]. 
 
Recently, there has been a lot of focus on the expansion of the murine liver during 
pregnancy. Pregnancy results in global changes to the size and function of many organs 
including the brain, pancreas and liver [191-193]. The maternal liver is found to almost 
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double in size by the 18th day of pregnancy [193]. This substantial increase in liver size 
is a result of increased mitosis and hypertrophy of hepatocytes [193]. Pregnancy-
dependent hepatomegaly closely resembles liver growth occurring in the regenerating 
liver. This is supported by the observation that a subset of genes regulating liver 
regeneration is activated during pregnancy-induced liver growth [193]. 
 
10. Role of chromatin in liver homeostasis and regeneration 
Although there are numerous advances in the understanding of liver development, 
homeostasis and regeneration, studies on the capacity of chromatin to influence these 
processes are lacking. Few recent reports linking chromatin and liver homeostasis or 
regeneration are summarized below. 
 
The circadian rhythm exists in the liver for the regulation of liver function and 
homeostasis. It was found that HDAC3 recruitment in the liver is required for the 
circadian rhythm. The circadian nuclear receptor Rev-erbα colocalizes with HDAC3 at 
genes governing lipid metabolism. Furthermore, depletion of HDAC3 results in hepatic 
steatosis [194]. 
 
Hepatic stellate cells are recognized for their role in fibrosis in response to injury. The 
transdifferentiation of these into cells similar to myofibroblasts is an essential process in 
wound healing and fibrosis. This process requires the recruitment of MeCP2 to methyl-
CpG marks on genomic DNA resulting in silencing of essential genes. This silencing is 
required for hepatic stellate cells to acquire their fibrogenic phenotype [195-197]. 
 
EZH1 and EZH2 are homologous proteins that form a part of PRC2 complex and possess 
H3K27 methyltransferase activity. EZH1 and EZH2 redundantly maintain liver 
homeostasis and regulate liver regeneration [198]. In the absence of EZH1 and EZH2, 
mutant mice exhibit regenerative nodules and fibrosis accompanied with a depletion of 
H3K27me3 at genes governing cell survival, proliferation and fibrosis. These mice also 
displayed an impaired regenerative response to partial hepatectomy [198]. 
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Focus of Dissertation 
 
The work described in this dissertation focuses on understanding the significance of CFP1 
in embryonic stem cell function and in the homeostasis and regeneration of the 
mammalian liver. 
 
The first part of this work describes the interaction between CFP1 PHD and methylated 
H3K4. Critical residues required for this interaction were mutagenized and the functional 
significance of this interaction was assessed by expressing these CFP1 mutations in 
CXXC1−/− ES cells and assaying for rescue of defects that occur in the absence of CFP1. 
Subnuclear localization of endogenous H3K4me3 was studied by confocal 
immunofluorescence whereas the ability of CXXC1−/− ES cells expressing CFP1 mutations 
to differentiate in vitro, was assessed by morphological characteristics, alkaline 
phosphatase activity and RT-PCR analysis of stem cell and lineage-specific markers. 
The second part of this work describes the interaction between CFP1 PHD and 
unmodified H3. Several point mutations were made within CFP1 PHD to try and ablate 
its interaction with unmodified H3 to determine the functional significance of this 
interaction. Further research is required to precisely identify amino acid residues that are 
critical for this binding event, mutagenize them and investigate the functional role of this 
binding event. 
 
The third part of this work examines the importance of CFP1 in murine liver homeostasis 
and regeneration. This is the first study that suggests a role for CFP1 in long-term tissue 
homeostasis in an adult animal. A mouse line carrying the conditional CXXC1 allele and 
Cre-recombinase gene under the control of the liver-specific albumin promoter was 
established and their phenotypes were studied over an extended period of time. To 
understand the role of CFP1 in liver regeneration, CFP1-deficient mice were subjected to 
partial hepatectomy (surgical removal of 2/3 liver) and their liver growth response was 
assessed by comparing residual liver masses one week after the surgery. 
The goal of this dissertation is to enhance the understanding of the functional role of the 
epigenetic regulator CFP1 in ES cells and to determine the significance of CFP1 in the 
post-development homeostasis of quiescent liver tissue and in the regenerating liver. 
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Gaining insight into these roles of CFP1 will further the knowledge of the regulation of 
epigenetic machinery required for these processes. 
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Methods 
 
1. Cloning of plasmids 
The plasmid encoding GST-tagged Pygo2 PHD was generously provided by Dr. Xing Dai, 
University of California-Irvine, CA and the plasmid encoding GST-tagged HP1α 
chromodomain was obtained from a non-profit, global plasmid repository called 
Addgene. 
 
cDNA, encoding 1-656 amino acids and 1-102 amino acids of CFP1, was cloned into 
pcDNA 3.1/Hygro mammalian expression vector (Invitrogen, Carlsbad, CA) and pGEX-
4T1 (GE Healthcare, United Kingdom) respectively by sequential restriction digests by Dr. 
Jeong-Heon Lee. The plasmid maps and cloning strategies used for pcDNA 3.1/Hygro and 
pGEX-4T1 plasmids are schematically represented in Figures 3 and 4 respectively. 
 
pGEX-4T1 plasmids containing C-terminal and N-terminal truncations of CFP1 PHD 
domain were generated as follows. First, desired regions in CFP1 cDNA sequence were 
subjected to PCR amplification using specific oligonucleotide primers (Integrated DNA 
Technologies, San Jose, CA) (Table 3) using the parent pGEX-4T1 plasmid containing 
cDNA sequence for CFP1 (1-102 aa) as the template. These Taq-amplified PCR products 
(containing 3’ A-overhangs) were directly ligated to the pCR2.1®-TOPO® TA vector 
provided in the TOPO® TA cloning kit (Invitrogen) as per manufacturer’s instructions, 
followed by restriction digestion with XbaI and EcoRI (New England Biolabs, Ipswich, 
MA). The cDNA sequence encoding 1-102 aa of CFP1 was released from the parent 
plasmid by digestion using restriction enzymes XbaI and EcoRI to generate the empty 
vector. This was followed by ligation of the digested insert to the digested empty pGEX-
4T1 vector using T4 DNA ligase (New England Biolabs). Sequences of these plasmids 
were verified by automated sequencing carried out at the Indiana University Biochemistry 
and Biotechnology Facility (IU BBF). 
 
2. Site directed mutagenesis 
Single, double or triple amino acid substitutions or deletions of certain amino acid 
residues were performed by site-directed mutagenesis using the Quick Change II Site- 
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Figure 3: Cloning of a construct expressing FLAG-tagged CFP1 (1-656) protein. 
The human CFP1 cDNA (1968 bp) was ligated in the multiple cloning site in-frame 
between EcoRI and XbaI sites, downstream of the FLAG epitope cDNA sequence within 
the pcDNA 3.1 Hygro vector (5.6 kb) by Dr. Jeong-Heon Lee.  
 
pcDNA 3.1/Hygro 
CFP1 cDNA 
Nru1 
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Figure 4: Cloning of constructs expressing recombinant GST-tagged CFP1 PHD 
The human CFP1 cDNA encoding the CFP1 PHD domain (1-102) or its truncations 1-29, 
1-49, 1-73, 50-102, 1-55, 1-60, 1-65, 1-70 used for the expression of recombinant GST 
proteins, were ligated into the pGEX-4T1 vector (4.9 kb) between EcoRI and XbaI. 
  
 
pGEX-4T1 
cDNA 
EcoRI----CFP1 cDNA----XbaI 
GST 
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Table 3: List of oligonucleotide primers used to generate CFP1 PHD truncations 
Primers designed to generate CFP1 PHD truncations contained restriction site linkers for 
cloning of these constructs into pGEX-4T1. Forward and reverse primers are indicated by 
F and R/ Rev respectively. Numbers in the primer name suggest the location of the 
primer in terms of amino acids in CFP1. The EcoRI (GAATTC) restriction site sequence 
and the XbaI sequence (TCTAGA) was added to forward and reverse primers respectively 
(shown in bold). 
 
1. CFP1 F: 5’-GTACGAATTCATGGAGGGAGATGGTTCAGACCCAGAG-3’ 
2. CFP1 Rev 29 aa: 5’-CATGTCTAGAGCAGTAGATGGGCGCATTCTCCCCATTC-3’ 
3. CFP1 Rev 49 aa: 5’-CATGTCTAGACCACTCATTGCAGTTGTCACACCCG-3’ 
4. CFP1 Rev 73 aa: 5’-CATGTCTAGAGCACTCCCGACAGTACCACTCCCGG-3’ 
5. CFP1 50 to 102 F: 5’-GTACGAATTCATGTTCCATGGGGACTGCATCCGGATC-3’ 
6. CFP1 50 to 102 R: 5’-CATGTCTAGAGGGCTCACTGCTGTCCCGCTC-3’ 
7. CFP1 55 Rev: 5’-CATGTCTAGAGATGCAGTCCCCATGGAACC-3’ 
8. CFP1 60 Rev: 5’-CATGTCTAGACTTCTCAGTGATCCGGATGCAG-3’ 
9. CFP1 65 Rev: 5’-CATGTCTAGAGATGGCCTTGGCCATCTTCTC-3’ 
10. CFP1 70 Rev: 5’-CATGTCTAGAACAGTACCACTCCCGGATGG-3’ 
34 
Directed Mutagenesis kit (Agilent, Santa Clara, CA) as per manufacturer’s instructions. 
Fifty microliter reactions containing 50 ng of the template plasmid DNA, 125 ng of 
forward and reverse primers, 1 µl of 2’-deoxynucleoside 5’-triphosphate (dNTP) mix, 5 µl 
of 10X reaction buffer, 2.5 units of PfuUltra high fidelity DNA polymerase was subjected 
to thermocycling: 95°C for 30s followed by 18 cycles of 95°C for 30s, 55°C for 1 min, 
68°C for 7 min. This was followed by digestion of the parent plasmid by 1 µl of DpnI for 1 
hour at 37°C. Further, XL-1 Blue super competent cells were transformed with 1 µl of 
DpnI–treated DNA. Transformed bacteria were spread on LB agar plates containing 100 
µg/ml of Ampicillin and grown overnight at 37°C. Individual clones were selected, grown 
in LB overnight at 37°C with shaking and these cultures were subjected to plasmid mini-
preparations. The sequence of each plasmid was confirmed for integrity and the presence 
of the expected mutation by IU BBF or Eurofin MWG Operon sequencing services. The 
oligonucleotide primers used to generate various mutations are listed in Table 4. 
 
3. Plasmid purification: Small scale and large scale 
For small scale plasmid purification, 5-6 ml of LB media containing Ampicillin at 100 
µg/ml was inoculated with a single transformed colony for overnight growth at 37°C with 
shaking at 240 rpm. Bacteria were pelleted and mini preparations (for upto 20 µg yield of 
plasmid DNA) were done using a plasmid miniprep kit (Sigma-Aldrich, St. Louis, MO) as 
per manufacturer’s protocol. 
 
To obtain large scale quantities of plasmid DNA (upto 500 µg yield of plasmid DNA), 3 ml 
of LB media supplemented with 100 µg/ml Ampicillin was inoculated with a single 
bacterial colony and grown at 37°C with shaking at 240 rpm. The 3 ml culture was added 
to 200 ml LB containing 100 µg/ml Ampicillin and grown overnight. Cultures were 
pelleted at 4000 rpm for 15 min at 4°C and plasmid DNA was isolated using a maxiprep 
kit (Qiagen, Valencia, CA) as per manufacturer’s recommendations. 
 
4. Transformation of plasmids:  
To transform the plasmid of interest that presents ampicillin resistance property to the 
cells, 1 µl of chilled plasmid DNA was added to 15 µl of α-select competent cells (Bioline,
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Table 4: List of oligonucleotide primers used for site-directed mutagenesis 
The following primers used for site-directed mutagenesis contain nucleotide changes 
resulting in single, double or triple amino acid substitutions. F and R indicate forward 
and reverse primers respectively. Nucleotide changes for various mutations are shown 
after the primer name whereas missense codons are represented in bold in the forward 
primers. 
 
1. Y28A F: TACGCA 5’-GAGAATGCGCCCATCGCATGCATCTGCCGCAAAC-3’ 
2. Y28A R: 5’ GTTTGCGGCAGATGCATGCGATGGGCGCATTCTC-3’ 
3. D44A F: GACGCC 5’ CTTCATGATCGGGTGTGCCAACTGCAATGAGTGG-3’ 
4. D44A R: 5’-CCACTCATTGCAGTTGGCACACCCGATCATGAAG-3’ 
5. W49A F: TGGGCC 5’-GTGTGACAACTGCAATGAGGCCTTCCATGGGGACTGCATCC-3’ 
6. W49A R: 5’-GGATGCAGTCCCCATGGAAGGCCTCATTGCAGTTGTCACAC-3’ 
7. D44A-W49A F: GACGCC, TGGGCG  
5’-GCCAACTGCAATGAGGCGTTCCATGGGGACTG-3’ 
8. D44A-W49A R: 5’-CAGTCCCCATGGAACGCCTCATTGCAGTTGGC-3’ 
9. G42P F: GGGCCG 5’-CAACTGCTTCATGATCCCGTGTGACAACTGCAATG-3’ 
10. G42P R: 5’-CATTGCAGTTGTCACACGGGATCATGAAGCAGTTG-3’ 
11. C29A F: TGCGCA 5’ GAGAATGCGCCCATCTACGCAATCTGCCGCAAACCGGAC-3’ 
12. C29A R: 5’-GTCCGGTTTGCGGCAGATTGCGTAGATGGGCGCATTCTC-3’ 
13. C73A F: TGCGCG 5’-GAGTGGTACTGTCGGGAGGCGAGAGAGAAAGACCCCAAG-3’ 
14. C73A R: 5’-CTTGGGGTCTTTCTCTCTCGCCTCCCGACAGTACCACTC-3’ 
15. C70A F: TGTGCT 5’-TCCGGGAGTGGTACGCTCGGGAGTGCAGAG-3’ 
16. C70A R: 5’ CTCTGCACTCCCGAGCGTACCACTCCCGGA-3’ 
17. C43A C46A F: TGTGCT, TGCGCC 
5’CAACTGCTTCATGATCGGGGCTGACAACGCCAATGAGT GGTTCCATGGG3’ 
18. C43A C46A R: 5’CCCATGGAACCACTCATTGGCGTTGTCAGCCCCGATCATGAAGCAGTTG3’ 
19. C31A F: TGCGCC 5’-GCCCATCTACTGCATCGCCCGCAAACCGGACATC-3’ 
20. C31A R: 5’-GATGTCCGGTTTGCGGGCGATGCAGTAGATGGGC-3’ 
21. H51A,C54AF: CATGCT, TGCGCC 
5’-CGCCAATGAGTGGTTCGCTGGGGACGCCATCCGGATCACTGAG3’ 
22. H51A, C54A R: 5’-CTCAGTGATCCGGATGGCGTCCCCAGCGAACCACTCATTGGCG-3’ 
23. C70A, C73A F: TGTGCG, TGCGCG 5'-CGGGAGTGGTACGCGCGGGAGGCGAGAG-3' 
24. C70A, C73A R: 5'-CTCTCGCCTCCCGCGCGTACCACTCCCG-3' 
25. R56A F: CGGGCG 5’- CATGGGGACTGCATCGCGATCACTGAGAAGATG-3’ 
26. R56A R: 5’-CATCTTCTCAGTGATCGCGATGCAGTCCCCATG-3’ 
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27. E59A F: GAGGCG 5’-CATCCGGATCACTGCGAAGATGGCCAAG-3’ 
28. E59A R: 5’-CTTGGCCATCTTCGCAGTGATCCGGATG-3’ 
29. K60A F: AAGGCG 5’-CATCCGGATCACTGAGGCGATGGCCAAGGCCATC-3’ 
30. K60A R: 5’-GATGGCCTTGGCCATCGCCTCAGTGATCCGGATG-3’ 
31. REK-AAA F: CGGGCG, GAGGCG, AAGGCG 
5’-CATGGGGACTGCATCGCGATCACTGCGGCGATGGCCAAGG CCATC-3’ 
32. REK-AAA R: 5’-GATGGCCTTGGCCATCGCCGCAGTGATCGCGATG 
CAGTCCCCATG-3’ 
33. REK-GGG F: CGGGGG, GAGGGG, AAGGGG 
5’-TGGGGACTGCATCGGGATCACTGGGGGGATGGCCAAGGCC-3 
34. REK-GGG R: 5’- GGCCTTGGCCATCCCCCCAGTGATCCCGATGCAGTCCCCA-3’ 
35. REK-PPP F: CGGCCG, GAGCCG, AAGCCG 
5’-CATGGGGACTGCATCCCGATCACTCCGCCGATGGCCAAGGCCATC-3’ 
36. REK-PPP R: 5’-GATGGCCTTGGCCATCGGCGGAGTGATCGGGATGCAGTCCCCATG-3’ 
37. DEL 55-60 F: 5’-TTCCATGGGGACTGCATGGCCAAGGCCATC-3’ 
38. DEL 55-60 R: 5’-GATGGCCTTGGCCATGCAGTCCCCATGGAA-3’ 
37 
Taunton, MA) that was thawed on ice. This mixture of plasmid DNA/competent cells was 
incubated on ice for 20 min followed by heat shock at 42°C for 40 seconds. After addition 
of 300 µl of LB, the reaction was shaken at 37°C for an hour at 240 rpm. The competent 
cells were spread onto LB agar petri plates containing 100 µg/ml ampicillin for overnight 
growth at 37°C or until isolated colonies appeared on the plates. 
 
5. Cell culture 
Cells were routinely cultured in a CO2 incubator (Thermo Scientific, Waltham, MA) at 
37°C and 5% CO2. The Human Embryonic Kidney-293 (HEK-293) cell line was grown on 
tissue culture dishes (Midwest Scientific, St. Louis, MO) in Dulbecco’s Modified Eagle’s 
medium (Gibco BRL Life Technologies, Grand Island, NY) enriched with 10% Hyclone 
Fetal Clone III Serum (GE Healthcare) and 100 units/ml of penicillin/streptomycin 
(Invitrogen). Murine ES cells (CCE 916) were cultured on tissue culture dishes coated 
with 0.1% gelatin in Dulbecco’s Modified Eagle’s medium enriched with 20% fetal bovine 
serum (Gibco BRL Life Technologies), 100 units/ml penicillin/streptomycin, 1.4% 
leukemia inhibitory factor (LIF)-conditioned media derived from chinese hamster ovary 
(CHO) cells (prepared by Erika Dobrota), 2mM L-glutamine (Invitrogen), 1% non-
essential amino acids (Invitrogen), 0.025% HEPES (pH 7.5, Invitrogen), 1% Hank’s 
balanced salt solution (Invitrogen) and 100nM β-mercaptoethanol. Fresh ES media was 
replaced on cells every other day. 
 
6. Transient transfection 
Transient transfection was performed in HEK-293 cells using Lipofectamine 2000 
(Invitrogen) according to manufacturer’s protocol. Briefly, cells were grown in 10 cm 
dishes until they reached a confluency of 70-90%. Fresh media (10 ml) was added 4 
hours before transfection. Plasmid DNA (24 µg) was diluted in Opti-MEM medium 
(Invitrogen) to a volume of 1.5 ml and incubated at room temperature for 5 min. Sixty 
microliters of Lipofectamine 2000 were diluted in Opti-MEM medium to a volume of 1.5 
ml and incubated for 20 min. Diluted plasmid DNA (1.5 ml) and diluted Lipofectamine 
2000 (1.5 ml) were mixed and the 3 ml mixture was added to the cells. Cells were 
harvested after two days of growth in 37°C and 5% CO2. 
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7. Stable transfection 
In order to stably express CFP1 or its mutants in CXXC1-/- ES cells, 25 µg of pcDNA 
3.1/Hygro expression vector containing WT or mutant CFP1 cDNA sequence was 
electroporated into early passage (10-20) CXXC1-/- ES cells. The same expression vector 
without any CFP1 cDNA sequence was electroporated into CXXC1-/- ES cells to be used as 
vector control. 25 µg of plasmid DNA was linearized by overnight restriction digest using 
Nru1 restriction enzyme (New England Biolabs) at 37°C followed by inactivation of the 
enzyme at 65°C for 1 hour. Digested plasmid DNA was subjected to phenol-chloroform 
extraction followed by ethanol precipitation. ~200 ng of the purified digested plasmid 
was run on 1.5% agarose gels containing ethidium bromide to verify linearization of the 
plasmid by exposure to ultraviolet light. 
 
Approximately, 107 CXXC1−/− ES cells growing at a confluency of ~70% were harvested 
by trypsinization, washed in PBS and resuspended in electroporation buffer [25mM 
HEPES (pH 7.5)]. These cells were transferred to sterile 4 mm gap electroporation 
cuvettes (Midwest Scientific) and mixed with ~25 µg digested and purified plasmid DNA. 
Pulse control setting was set to infinity on the Gene Pulser II (Bio-rad, Hercules, CA) and 
the mixture of cells and plasmid DNA was vortexed briefly and electroporated at 300V 
and 500 µF capacitance. After electroporation, cells were transferred to gelatin coated 15 
cm tissue culture dishes containing fresh ES culture medium and were allowed to grow 
and recover for 48 hours at 37°C and 5% CO2. Transfected cells were then supplemented 
with culture medium containing 200 µg/ml of hygromycin B (Sigma) and grown for ~14 
days until individual clones appeared. These clones were picked and expanded thereby 
establishing stable cell lines. ES medium containing 200 µg/ml Hygromycin was replaced 
every other day throughout the procedure. However, for experiments, stably transfected 
ES cells were grown in ES medium containing 50 µg/ml Hygromycin. 
 
Confirmation of protein expression of each stable clone was done by western blot analysis 
using antiserum against CFP1. 
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8. Recombinant GST-protein purification  
A single bacterial colony containing the plasmid of interest was inoculated into 5 ml LB 
media containing ampicillin (100 µg/ml) for overnight growth at 37°C with shaking (240 
rpm). Further, 250 ml of LB-Ampicillin media was inoculated with the 5 ml starter 
culture and grown with shaking at 37°C until the OD600 of the culture reached a value 
~0.7. Cultures were induced with 0.1 mM Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
for 3 hours at room temperature followed by high speed centrifugation (6000 rpm) at 4°C 
to pellet bacteria followed by storage at -80°C to allow for lysis of cells by a freeze-thaw 
cycle. Pelleted bacteria were resuspended and lysed by sonication in GST binding buffer 
[25 mM Tris pH 7.5, 150 mM NaCl, 1 mM EDTA, 0.5% Triton X-100 (+1mM phenyl 
methyl sulphonyl fluoride (PMSF), 1X cOmplete protease inhibitor (Roche, Indianapolis, 
IN) added fresh)]. After high speed centrifugation (15000 rpm) at 4°C, the supernatant 
containing GST fusion protein was incubated with a 50% slurry of glutathione-agarose 
beads (Sigma) (pre-washed in GST binding buffer) with rocking for 3 hours at 4ºC. After 
3 subsequent washes of the beads with GST binding buffer, GST fusion proteins were 
eluted using a buffer containing 10 mM reduced glutathione and 50 mM Tris-HCl (pH 
8.0). Further, eluates were subjected to three sequential rounds of dialysis in 1X 
phosphate buffered saline (PBS). These proteins were separated by electrophoresis on an 
8% polyacrylamide gel followed by staining of the gel with Simply Blue Safe Stain 
(Invitrogen) in order to observe and compare the intensity of GST-protein bands against 
BSA standards (0.0125-2.5 µg) to allow rough estimation of GST-protein concentration. 
 
9. Micrococcal nuclease (MNase) treatment 
GST-proteins were subjected to micrococcal nuclease treatment according to a previously 
published protocol [199]. Briefly, GST-proteins prepared as above were dialysed in 
TGMC buffer containing 20 mM TrisHCl (pH 7.9), 20% glycerol, 5 mM MgCl2, 5 mM 
CaCl2, 0.1% NP-40, 1 mM DTT, 0.2 mM PMSF and 0.1 M NaCl. MNase (New England 
Biolabs) was added to the GST-protein dialyzed in TGMC at a concentration of 0.033 
U/µl and incubated at 30°C for 10 min after gentle mixing. Binding reactions were set up 
with MNase-treated GST-proteins as explained under ‘Histone peptide pulldown’. 
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10. In vitro binding assays 
a. Calf thymus histone pull-down assay 
Two micrograms of GST-protein were incubated along with 1 µg of calf thymus total 
histones (Worthington, Lakewood, NJ) in binding buffer (50mM Tris-HCl, pH 7.5, 1M 
NaCl, 1% NP-40, 0.5 mM EDTA, 1mM PMSF, 1X cOmplete protease inhibitor [Roche]) at 
4ºC overnight followed by 1 hour incubation with glutathione-agarose beads. Following 
three washes in binding buffer, proteins bound to beads were denatured by 1X SDS 
sample buffer (Laemmli) (50 mM Tris-HCl pH 6.8, 2% SDS, 10% glycerol, 1% β-
mercaptoethanol, 12.5 mM EDTA and 0.02 % bromophenol blue) and subjected to 
western blotting using antibodies against total H3, H3K4me1/me2/me3 and H3K9me3 
(Abcam, Cambridge UK) [200]. 
 
b. Histone peptide pulldown 
One microgram of biotinylated, N-terminal tail peptide (1-21 aa) of unmodified histone 
H3, H3K4me1/me2/me3 or H3K9me3 (AnaSpec EGT, Fremont CA) was incubated 
overnight at 4ºC with 2 µg purified GST-protein in a binding buffer composed of 50 mM 
Tris pH 7.5, 300 mM NaCl and 0.05% NP-40. Streptavidin sepharose beads (GE 
Healthcare) were then added for 1 hour to immobilize the biotinylated histone peptides 
and pull down the interacting CFP1 PHD domain. After extensive washing, 1X SDS 
sample buffer was added to the beads and western blotting was performed on the eluates 
using an antibody directed against the GST tag (Thermo Scientific). 
 
11. FLAG Immunoprecipitation 
Cells were collected by scraping with a cell scraper and rinsed in cold 1X PBS followed by 
resuspension in hypotonic solution 4ºC to allow swelling of cells. Cells were then lysed by 
Dounce homogenization 10 times. The resultant nuclear fraction was pelleted by 
centrifugation at 4000 rpm for 10 min at 4ºC. This fraction was incubated with 
cytoskeletal (CSK) buffer [10 mM PIPES (pH 6.8), 100 mM NaCl, 300 mM sucrose, 3 mM 
MgCl2, 1mM EGTA, 0.5% Triton X-100, 1% protease inhibitor cocktail (Sigma), 1 mM 
PMSF and 1mM DTT] and lysed by Dounce homogenization 30 times. The lysate was 
treated with 50 units of benzonase nuclease (Millipore, Billerica, MA) for 1 hour on ice to 
enable degradation of DNA followed by centrifugation at 13000 rpm at 4ºC for 15 min. 
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The nuclear extract was incubated for 3 hours with 50 µl of FLAG M2-conjugated agarose 
beads with rocking at 4ºC. Prior to incubation, these beads were freshly prepared by 
washing twice in 1X TBS [20mM Tris-HCl (pH 8.0), 150 mM NaCl], twice with 0.1 M 
glycine-HCl (pH 3.5) and again thrice in 1X TBS. Following incubation, beads were 
washed thrice in CSK buffer, boiled in 1X SDS sample buffer and subjected to western 
blot analysis. 
 
12. Preparation of Whole cell extract  
a. From liver tissue 
Approximately, 100 mg of liver tissue was weighed out and placed on dry ice. CSK buffer 
(300mM NaCl), containing protease inhibitors, was added to the liver tissue followed by 
homogenization using PTA 10S polytron (Dremel, Racine, WI) at the setting ‘medium’ for 
20 seconds. The lysate was placed on ice throughout the procedure. The lysate was then 
centrifuged at 3000 rpm for 5 min. The supernatant was collected carefully to avoid the 
fat layer into another microfuge tube. This was again centrifuged at 13000 rpm at 4ºC to 
remove the remnant cellular debris and the resulting supernatant was used as the protein 
extract. 
 
b. From cells in culture 
Approximately half a million healthy and exponentially growing cells were collected 
using a cell scraper, washed with 1X PBS and centrifuged at 1800 rpm for 3 min at 4ºC. 
CSK buffer, containing protease inhibitors, was added to lyse these cells by vortexing at 
high setting for seven intervals of 30 seconds each (3.5 min total). The lysate was 
centrifuged at 13000 rpm at 4ºC for 20 min to collect debris. The supernatant obtained 
was used as the protein extract. Protein concentration of the lysates was estimated by the 
Bradford method followed by western blotting [201]. 
 
13. Western Blot/Immunoblot analysis 
Protein concentration of cellular extracts was determined by the spectroscopic Bradford 
assay [201]. Samples were denatured by boiling in 1X sample buffer and subjected to 
electrophoresis on 8% for CFP1 protein and on 15% polyacrylamide gels for histone 
marks. Proteins were transferred onto polyvinylidene fluoride (PVDF) membrane; either 
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0.45 µM (GE Healthcare) for CFP1 protein or 0.2 µM (Millipore) for histone proteins. The 
membrane was incubated with primary antibody diluted in 5% blotting grade blocking 
reagent (Bio-rad) in TBS-T (20 mM Tris-HCl [pH 8.0], 150 mM NaCl, 0.1% Tween 20) 
for 1 hour at room temperature. The membrane was washed with TBS-T thrice for 10 
min and then incubated with appropriate secondary antibodies linked to horseradish 
peroxidase (GE Healthcare). After three TBS-T washes, the membrane was incubated 
with ECL detection reagent (GE Healthcare) followed by autoradiography. 
 
Photographic films were scanned on a flatbed scanner and bands were quantified by 
densitometry using ImageJ (NIH). In order to re-probe blots, they were washed twice in 
TBS-T followed by incubation in fresh, mild stripping buffer [200 mM glycine, 0.1% SDS, 
1% Tween 20, pH 2.2] twice at room temperature. This was followed by two washes in 
1X PBS and 1X TBS-T for 10 minutes each. Blots were checked for any remnant signal 
from the earlier probe by incubation with ECL reagents and exposing the X-ray film. After 
washing the blot in TBS-T, re-probing was done as explained above. 
 
The following antibodies were used for western blot analyses: 
a. Polyclonal rabbit CFP1 antiserum [64] 
b. Polyclonal rabbit anti H3K4me1, H3K4me2, H3K4me3, H3K9me3 and anti-total H3 
(Abcam) 
c. Polyclonal rabbit anti-GST (Thermo Scientific) 
d. Mouse monoclonal anti β-actin (Sigma) 
 
14. Confocal microscopy  
ES cells (2x104) were seeded onto sterile coverslips placed on each well of a 24 well 
tissue culture dish and grown for 2 days. ES medium was removed and cells were washed 
twice with cold 1X PBS. Further, cells were fixed using 4% paraformaldehyde for 20 min 
at room temperature followed by three washes with cold 1X PBS. Cells were then 
permeabilized in PBS-T (0.5% Triton X-100 in PBS) for 10 min followed by a single wash 
with 1X PBS. Blocking buffer (1% BSA, 5% Normal Donkey Serum (Santacruz 
Biotechnologies, Santa Cruz, CA in PBS-T) was prepared fresh and added for 1 hour at 
room temperature with gentle rocking. After a wash with 1X PBS, the primary antibody 
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for H3K4me3 (Abcam) was diluted in blocking buffer (1:100) and added to the cells for 
overnight incubation at 4ºC. The next day, cells were washed three times in 1X PBS and 
incubated with FITC conjugated secondary antibody (Santa Cruz) diluted 1: 200 in 
blocking buffer for 2 hours at room temperature. After 3 washes with 1X PBS, cells were 
stained with 0.1 µg/ml of 4’, 6-diamidino-2-phenylindole (DAPI) solution for 20 min at 
room temperature. Coverslips were washed once in sdH20 and twice in 1X PBS before 
mounting on slides with Vectashield mounting medium (Vector Laboratories, Burlingame, 
CA). A Zeiss LSM 700 confocal imaging system (Department of Ophthalmology, Eugene 
and Marilyn Glick Eye Institute) was used to observe staining patterns of nuclei. This 
system utilized excitation wavelengths of 405 nm and 488 nm for visualizing DAPI 
staining and FITC staining respectively. Images obtained were analyzed using MetaMorph 
v7 (Molecular Devices, Sunnyvale, CA) with similar thresholding values for each image. 
Thresholding for DAPI was done so as to include DAPI bright regions whereas for FITC, 
thresholding was performed to exclude background and non-specific staining. Percent 
colocalization of H3K4me3 over DAPI was determined for at least 15 nuclei for every cell 
line using the MetaMorph colocalization module. 
 
15. Morphological analysis of embryonic stem cell differentiation 
ES cells growing at around 50-70 % confluency were trypsinized and washed thrice in ES 
media without LIF. The number of viable cells was determined using a hemocytometer by 
trypan blue dye exclusion and 3.5x105 cells were plated on bacterial culture dishes in ES 
media lacking LIF. Around 7-8 ml of fresh ES media without LIF was replaced every day 
for 10 days. At the end of 10 days, morphology of cells was studied by microscopic 
analysis (Leica Microystems, Dr. Dai Lab) at 10X magnification. 
 
16. Measure of Embryonic Stem Cell Differentiation : Leukocyte alkaline 
phosphatase assay 
ES cells were processed as in Method 11. Further, ten days after initial plating, cells were 
trypsinized and disaggregated into a single cell suspension and plated on gelatin-coated 
tissue culture dishes in ES media lacking LIF and were allowed to recover overnight. 
Staining for alkaline phosphatase was done using a leukocyte alkaline phosphatase 
detection kit (Sigma). Adherent ES cells were washed in 1X PBS and fixed with citrate 
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fixative (18 mM citric acid, 9 mM NaCl, 12 mM surfactant buffered at pH 3.6) for 2 min 
at room temperature. Cells were washed with sterile distilled water (sdH2O) and alkaline 
phosphatase staining solution, prepared according to the manufacturer’s protocol, was 
added to the cells. The cells were incubated with this staining solution for 15 min 
followed by a wash with sdH2O. These cells were immediately visualized under a 
microscope (Leica) and images were taken at 10X magnification. Cells positive for 
alkaline phosphatase activity are stained reddish purple in color while cells that are 
negative remained unstained. A minimum of 300 cells were scored for each dish. 
 
17. RNA isolation, cDNA synthesis and semi-quantitative PCR for analysis of stem 
and lineage markers 
Undifferentiated and differentiated ES cells were collected on Day 0 (day of seeding) and 
Day 10 (ten days after growth in ES media lacking LIF) for analysis of stem and lineage 
specific mRNA during in vitro differentiation. Total RNA was isolated from these cells 
using RNeasy Mini kit (Qiagen) as per manufacturer’s directions. cDNA was generated 
using the iScript cDNA synthesis kit (Bio-rad). Briefly, 1 µg of RNA template was 
combined with 4 µl of 5X iScript reaction mix, 1 µl of iScript reverse transcriptase and 
nuclease free water to a total volume of 20 µl and was subjected to the following 
thermocycling conditions: 5 minutes at 25ºC, 30 minutes at 42ºC and 5 minutes at 85ºC. 
 
One microliter of single stranded cDNA obtained from the above step was amplified by 
semi-quantitative PCR in a 50 µl reaction mixture containing 50 pmole of specific forward 
and reverse primers (Table 5), 0.2 mM each deoxynucleotide triphosphate (dNTP), 0.75 
unit Taq DNA polymerase (Roche) and 1X reaction buffer (Roche). The following 
thermocycling conditions were used: Initial denaturation at 94ºC for 2 min followed by 
30 cycles (24 cycles for Oct4) at 94ºC for 30s, 55ºC-60ºC for 30s, 72ºC for 30s and a 
terminal elongation step of 72ºC for 10 min. After amplification, 25 µl of the reaction 
product was electrophoresed on 1.5% agarose gels containing ethidium bromide and 
were visualized by exposure to ultraviolet light. 
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18. Genomic DNA isolation 
To isolate genomic DNA from tail-biopsy specimens or liver tissue samples, 600 µl of cell 
lysis buffer (10 mM Tris [pH 8.0], 100 mM EDTA, 0.5% SDS) was added along with 200 
µg of Proteinase K (Roche) to allow digestion of the tissue overnight at 50ºC. The digests 
were then incubated with 6 µl of RNase A (Roche, 10mg/ml) at 37ºC for 15 min. The 
tubes were chilled on ice and 200 µl of 7.5 M Ammonium acetate solution was added to 
precipitate proteins followed by brief vortexing and incubation on ice for 10 min. The 
sample was then centrifuged at 13000 rpm at 4ºC to pellet proteins. The supernatant 
(~750 µl) was transferred to another microfuge tube and 525 µl of isopropanol was 
added and mixed thoroughly by tube inversion. The isolated DNA was centrifuged for 2 
min at 13000 rpm at room temperature and supernatant was discarded. The DNA pellet 
was rinsed with 70% ethanol, air dried and re-suspended in a suitable amount of sdH2O. 
 
19. Animal studies 
a. Generation of CXXC1 fl/fl AlbCre+ mouse line 
Studies involving mice were designed and executed in adherence to the Guide for the 
Care and Use of Laboratory Animals (Guide, NRC 2011). In order to understand the 
importance of CFP1 in an adult animal, a mouse strain of the C57BL/6 background, 
carrying a conditional (floxed) allele of the CXXC1 gene (CXXC1fl/fl) was generated 
[176]. To further study the significance of CFP1 in liver development and regeneration, 
CXXC1fl/fl mice were bred with AlbCre mice [C57BL/6-TgN(AlbCre)21Mgn] purchased 
from The Jackson Laboratory (Bar Harbor, Maine) [202]. The AlbCre mice carry the Cre-
recombinase gene under the control of the liver-specific albumin promoter. All pups born 
from the breeding of CXXC1fl/fl and AlbCre mice were heterozygous for the conditional 
allele (CXXC1+/fl), with or without the AlbCre transgene (AlbCre+/−). Further, CXXC1+/fl 
AlbCre+ mice were bred with CXXC1+/fl AlbCre− mice to obtain pups homozygous for 
the conditional allele and carrying the Cre transgene (CXXC1fl/fl AlbCre+) to be used as 
experimental animals. This breeding scheme also resulted in a roughly equivalent number 
of CXXC1fl/fl AlbCre− animals that were utilized as controls for experiments. Male 
CXXC1fl/fl AlbCre+ mice and female CXXC1fl/fl AlbCre− mice were paired for breeding to 
prevent offspring from having two copies of the Cre transgene. Verification of genotypes 
was performed by PCR on genomic DNA obtained from tail-biopsy specimens using the 
46 
Table 5: List of Primers used for RT-PCR Analysis of stem cell and lineage 
development markers 
 
1. c-fms : 5’-CTGAGTCAGAAGCCCTTCGACAAAG-3’ 
: 5’-CTTTGCCCCAGACCAAAGGCTGTAGC-3’ 
2. gp-II B  : 5’-AGGCAGAGAAGACTCCGGTA-3’ 
: 5’-TACCGAATATCCCCGGTAAC-3’ 
3. βH1  : 5’-AGTCCCCATGGAGTCAAAGA-3’ 
: 5’-CTCAAGGAGACCTTTGCTCA-3’ 
4. GATA-4  : 5’-CACTATGGGCACAGCAGCTCC-3’ 
: 5’-TTGGAGCTGGCCTGCGATGTC-3’ 
5. Oct-4  : 5′-GGCGTTCTCTTTGGAAAGGTGTTC-3 
: 5′-CTCGAACCACATCCTTCTCT-3′ 
6. HPRT  : 5′-CACAGGACTAGAACACCTGC-3′ 
: 5′-GCTGGTGAAAAGGACCTCT-3′ 
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primers LOXP1F: 5′-TGTAGACACTTGTGGGAAGCC and CXXC1R: 5′-
AGTTCACCCAGACCCTCTTC-3′ [176]. The presence of the LoxP sites in the CXXC1 
conditional allele results in a PCR fragment slightly larger than that produced from the 
WT allele. The presence or absence of the Cre transgene was determined by PCR on the 
tail-DNA using primers oIMR 1084: GCGGTCTGGCAGTAAAAACTATC and oIMR 1085: 
GTGAAACAGCATTGCTGTCACTT (The Jackson Laboratories) (Figure 5A and 5B). 
 
b. Confirmation of CXXC1 deletion specifically in the liver 
Five and ten week old male mice, heterozygous for the conditional allele and carrying the 
Cre transgene (CXXC1+/fl AlbCre+), were sacrificed and tissues from the liver, lung, 
spleen, kidney were collected in microfuge tubes. Genomic DNA was isolated from these 
tissue samples as described above. In order to determine if CXXC1 was deleted 
specifically in the liver, genomic DNA obtained from tissues of various organs was used as 
templates in two distinct PCR reactions. In the first PCR reaction, primers LOXP1F and 
LOXP3R: 5’-GTTCCTGCTCAAAGAGCTCG-3’ were utilized. In the other PCR reaction, 
primers LOXP1F and CXXC1R were used, as in PCRs performed for genotype 
determination. The location of the primers used and expected sizes of DNA fragments 
resulting from PCR amplification is shown in Figure 5A. 
 
c. Partial hepatectomy (PH) surgery 
Five male CXXC1fl/fl AlbCre+ and CXXC1fl/fl AlbCre−mice aged 2-3 months or 5-6 months 
were subjected to PH. This surgery was carried out by Dr. Guoli Dai, The Department of 
Biology, IUPUI according to a previously published protocol [203]. Briefly, mice were 
anesthetized by a 3% flow of isofluorane and an oxygen flow rate of 2L/min in an 
anesthesia chamber available in the surgery rooms at IUPUI Animal Facility. Anesthesia 
was maintained during the surgery at 2% flow of isofluorane and an oxygen flow rate of 
0.8L/min. After mice were adequately anesthetized, their initial body mass was 
determined. Further, their upper abdomens were disinfected with 70% ethanol and were 
placed on a warming pad to prevent the risk of hypothermia during surgery. A midline 
incision was made on the upper abdomen and the three anterior lobes: right upper lobe, 
left upper lobe and left lower lobe (2/3 liver) were tied at the lobe origins and resected. 
The peritoneum was rejoined using a running 4-0 silk suture and skin was closed using 
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Figure 5: Schematic representation of the linear sequence of the WT CXXC1 allele, 
conditional CXXC1 allele and the disrupted allele and genotyping analysis of 
transgenic mice 
A) Arrows indicate the position and direction of oligonucleotide primers designed to 
evaluate recombination events occurring after induction of Albumin-Cre. Expected sizes 
of DNA fragments after PCR amplification are indicated. 
B) DNA isolated from tail-biopsy specimens was amplified by PCR using primers 
LoxP1F and CXXC1R for the conditional allele; and oIMR 1084 and oIMR 1085 for the 
Cre transgene. The amplified products were subjected to electrophoresis on a 1% agarose 
gel containing ethidium bromide and visualized by exposure to ultraviolet light for 
analysis of genotype. 
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wound closure clips. This was followed by subcutaneous administration of sterile saline 
(3 ml) to replace any loss of fluid during surgery. The total time from start till finish of 
the surgery was limited to 15 min to reduce trauma. The mice were occasionally placed 
under warming lights to ease the process of coming out of anesthesia. Seven days after  
PH, mice were sacrificed and body mass and masses of the right kidney and remnant liver 
were recorded. A sample of the remnant liver was collected for protein analysis and 
another was placed in tissue embedding cassettes and fixed in 10% neutral buffered 
formalin solution for tissue sectioning. A small piece of tissue was mounted in OCT 
embedding compound (Tissue-Tek), placed on heptane on top of dry ice to allow gradual 
freezing and was stored at -80°C for future use. 
 
20. Histone protein preparation from liver tissue  
Liver tissue samples were weighed, placed on dry ice and cut into small pieces with a 
scalpel. These pieces were transferred into a Dounce homogenizer followed by addition 
of 1 ml of TEB buffer (PBS containing 0.5% Triton X 100, 2 mM PMSF and 0.02% NaN3) 
for every 200 mg of tissue. Pieces of liver tissue were disaggregated by 60 strokes, 
transferred to a microfuge tube and centrifuged at 13000 rpm for 5 min at 4°C. 
Supernatant was removed and the tissue pellet was resuspended in 3 volumes of 
extraction buffer (0.5 N HCl, 10% glycerol) to allow extraction of histones. This mixture 
was incubated on ice for 30 min followed by centrifugation at 13000 rpm at 4°C. Eight 
volumes of acetone were added to the resultant supernatant fraction followed by 
overnight incubation at -20°C. This fraction was centrifuged at 13000 rpm for 5 min and 
the histone pellet was air-dried and further dissolved in 100 µl of distilled water. Histone 
proteins were quantified by the Bradford method [201] and stored at -80°C in aliquots. 
 
21. Histopathological analysis: Hematoxylin & Eosin (H&E) staining 
Liver tissues were placed in embedding cassettes and chemically fixed by submerging in 
10% neutral buffered formalin solution. These cassettes were transferred to 70% ethanol 
and sent to Department of Pathology and Laboratory Medicine, IUSM for routine 
processing service that includes paraffin embedding and sectioning of paraffin blocks into 
5 µm slides followed by the standard histopathological H&E staining. Liver pathology was 
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examined by Dr. Harm HogenEsch, Purdue University College of Veterinary Medicine, 
West Lafayette, IN. 
 
22. Statistical analysis 
Data presented in this dissertation were evaluated for statistical significance by unpaired, 
two-tailed Student’s t-test with equal variance. A difference of p-value ≤ 0.05 was 
considered to be statistically significant. Error bars represent Standard Error of the Mean 
(SEM). Graphical and statistical analyses were performed with Microscoft Excel and 
GraphPad Prism 6 softwares. 
  
52 
Results 
 
1. Characterization of the interaction between CFP1 and methylated H3K4 
a. The N-terminal CFP1 PHD binds H3K4me1/me2/me3 
PHDs are frequently found in chromatin remodeling proteins and are known to interact 
with either modified or unmodified histone tails [123, 124, 126]. The domain structure 
of CFP1 consists of an N-terminal PHD that spans from amino acids 27-73. Comparison of 
the N-terminal PHD of CFP1 to other known histone H3K4me2/3 binders such as PHF2, 
ING2 and BPTF [125, 128, 131] revealed the conservation of crucial H3K4me3 binding 
residues; Y28, D44 and W49 (enclosed in boxes in Figure 6A). To examine its histone 
binding properties, human CFP1 PHD was bacterially expressed as a GST-fusion protein 
[GST-CFP1 PHD (1-102aa)] and pulldowns were performed with bulk calf thymus 
histones. Western blotting using antibodies against H3K4me1, H3K4me2 and H3K4me3 
and total H3 revealed the association of GST-CFP1 PHD with these marks. However, GST-
CFP1 PHD was unable to bind H3K9me3, a heterochromatin mark. (Figure 6B). This 
finding was further validated by performing histone peptide pulldown using biotin-
labelled histone H3 N-terminal tail peptides (1-21aa) modified at various sites of 
methylation. It was found that GST-CFP1 PHD was specifically retained by biotinylated 
histone tail peptides H3K4me1, H3K4me2, H3K4me3 but not by H3K9me3 (Figure 6C). 
To ensure that the lack of binding of GST-CFP1 PHD to H3K9me3 was not a false-
negative result, the ability of the H3K9me3 peptide tail to bind a known H3K9me3 
reader, the N-terminal chromodomain of HP1α, was assessed. It was found that GST-
tagged chromodomain of HP1α was able to interact with the H3K9me3 histone peptide 
tail (Figure 6D). 
 
b. Mutations in CFP1 PHD ablate its binding to H3K4me3 
When the putative H3K4me3 binding residues in GST-CFP1 PHD (Y28, D44 and W49) 
were mutated individually to alanine by site-directed mutagenesis and in-vitro histone 
peptide pulldowns were subsequently performed, a dramatic reduction in the binding of 
the GST-CFP1 PHD domain to the H3K4me3 tail peptide was observed (Figure 7A).  
Moreover, in order to understand the histone binding properties of CFP1 in vivo, the 
mammalian expression vector, pcDNA3.1 Hygro/Flag, containing WT or mutated forms
53 
 
Figure 6: The N-terminal PHD of CFP1 binds H3K4me1/me2/me3 
A) Sequence comparison of CFP1 PHD and PHDs in other known H3K4me3 binders: 
PHF2 (PHD finger protein 2), ING2 (Inhibitor of growth protein 2) and BPTF 
(Bromodomain PHD finger transcription factor) was performed using the Clustal O 
program. Conserved residues important for H3K4me3 binding are enclosed in boxes.  
B) Purified GST-CFP1 PHD or GST was incubated with a mixture of calf thymus 
histones followed by addition of GSH agarose beads to immobilize the formed complex. 
Bound histone proteins were analyzed by immunoblotting (IB) using antisera against 
mono, di or trimethylated H3K4, trimethylated H3K9 and total H3. 
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C) Histone peptide pulldowns were performed wherein purified GST-CFP1 PHD was 
incubated with N-terminal, biotin-labelled histone H3 peptides (1-21aa) carrying the 
indicated modifications followed by addition of streptavidin sepharose beads. Bound 
proteins were analyzed by immunoblotting (IB) with GST antiserum.  
D) Histone peptide pulldown was performed wherein purified GST-HP1 
chromodomain was incubated with N-terminal, biotin-labelled histone H3K9me3 peptide 
(1-21aa) followed by addition of streptavidin sepharose beads. Bound protein was 
analyzed by immunoblotting (IB) with GST antiserum. 
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 Y28A, D44A and W49A) of full length CFP1 cDNA were transiently transfected into HEK-
293 cells. Nuclear extracts were prepared and Flag-CFP1 was immunoprecipitated from 
these extracts using Flag M2-conjugated agarose (Sigma). The immunoprecipitated 
material was subjected to western blot analysis for the endogenous H3K4me3 mark using 
antiserum against H3K4me3. It was found that the full length form of WT CFP1 was able 
to interact with endogenous H3K4me3 but the three point mutant forms of full length 
CFP1 completely abolished this interaction in vivo (Figure 7B). 
 
c. Isolation of stable CXXC1−/− ES clones expressing CFP1 point 
mutations 
CXXC1−/− ES cells are viable but exhibit a number of defects in comparison to CXXC1+/+ 
ES cells. These pleiotropic defects can be rescued by introduction of a full length CFP1 
expression vector (1-656aa) into CXXC1−/− ES cells [177]. This ability of wild type CFP1 
to rescue defects in CXXC1−/− ES cells was used as a tool to probe for structure function 
relationships of CFP1 [180]. To understand the functional significance of the interaction 
of CFP1 with methylated H3K4, various mutated forms of FLAG-tagged CFP1 (1-656) 
were stably expressed in CXXC1−/− ES cells and were further analyzed for rescue function 
(Figure 8A). CXXC1−/− ES cells expressing full length FLAG-tagged CFP1 (1-656) and 
CXXC1−/− ES cells expressing only the vector backbone without the CFP1 sequence (VEC) 
were isolated to be utilized as positive and negative controls, respectively, in subsequent 
experiments. CFP1 protein levels were determined for every stable clone by western blot 
analysis using an antiserum against CFP1 (Figure 8B). 
 
Previous studies indicate that ES cells that are heterozygous for the disrupted CXXC1 
allele (CXXC1+/−) do not show a defective phenotype despite expressing ~ 50% CFP1 
protein compared to CXXC1+/+ ES cells [177]. Hence, stably transfected ES clones 
expressing at least 50% of the level of CFP1 in comparison to WT ES cells were used for 
analysis of rescue function. Western blots for CFP1 were performed at regular intervals 
during the course of rescue experiments to ensure that CFP1 expression in the stable 
clones was maintained above 50% compared to CXXC1+/+ ES cells. 
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Figure 7: Mutations in CFP1 PHD ablate its binding to H3K4me3 
A) GST-CFP1 PHD (WT or the indicated mutants) were incubated with biotin-
labelled H3K4me3 peptide followed by pull down (PD) with streptavidin sepharose. 
Bound proteins were analyzed by immunoblotting (IB) with GST antiserum. 
B) Benzonase-treated nuclear extracts prepared from HEK-293 cells transiently 
expressing WT or mutant Flag CFP1 (1-656) were subjected to Flag immunoprecipitation. 
Binding of Flag-CFP1 to H3K4me3 was analyzed by immunoblotting with H3K4me3 
antiserum. 
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Figure 8: Isolation of stable CXXC1−/− ES clones expressing CFP1 point mutations 
A) A schematic representation of full length CFP1 along with amino acid positions of 
each domain followed by CFP1 mutations that were stably expressed in CXXC1−/− ES 
cells. The “X” indicates the approximate location of the indicated point mutation within 
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full length CFP1. The black circle at the N-terminus of CFP1 represents the Flag tag. The 
nomenclature of each of the stably expressed constructs used in this dissertation is 
represented on the right of the respective schematic. 
B) Immunoblot analysis was performed on whole cell lysates obtained from stable ES 
clones using CFP1 antiserum to determine the protein expression level of CFP1 which 
was compared to CFP1 expression in CXXC1+/+ ES cells. The membrane was re-probed 
with β-actin antiserum for analysis as a loading control. A representative immunoblot of 
three independent experiments is shown. 
59 
Taking into account that the CFP1 transgene might have become incorporated into a 
functionally important region of the genome, thereby altering the interpretation of rescue 
activity, two to three independent clones were analyzed in subsequent rescue 
experiments. 
 
In order to avoid the possibility of increased passage number (number of times the cells 
have been sub-cultured) from affecting results, stable clones were expanded and at least 
5 vials were frozen for each independent clone immediately after stable selection (at 
passage 1-3) and thereafter, cells from lower passage numbers (10-15) were used for 
experiments. 
 
d. Binding of CFP1 PHD to methylated H3K4 is dispensable for 
appropriate targeting of H3K4me3 to euchromatin in ES cells 
Chromatin is divided into two distinct forms based on the level of transcriptional activity. 
A tightly packed form known as heterochromatin, is usually transcriptionally silent. DAPI 
(4', 6-diamidino-2-phenylindole) is a fluorescent stain that preferentially associates with 
double stranded DNA. Heterochromatic regions are characteristically observed as DAPI-
bright regions after staining with DAPI. On the other hand, the less intensely stained 
form, known as euchromatin, has a relatively open conformation and is usually under 
active transcription. 
 
Previous studies in the lab suggest that CXXC1−/− ES cells show an inappropriate 
mislocalization of H3K4me3 to DAPI-bright heterochromatin region. Moreover, 
introduction of a DNA binding CFP1 mutant [C169A (1-656)] into CXXC1−/− ES cells did 
not rescue this defect suggesting that CFP1-DNA interaction is important for appropriate 
H3K4me3 targeting [179]. However, this interaction is not essential for the rescue of 
H3K4me3 targeting to the transcription start sites of housekeeping genes [181]. Hence, it 
was hypothesized that domains of CFP1 other than CXXC might be required for 
appropriate genomic targeting of H3K4me3 marks to euchromatin. To address the 
importance of the interaction of CFP1 PHD with methylated H3K4, for appropriate 
targeting of H3K4me3 marks to euchromatin, sub-nuclear localization of endogenous 
H3K4me3 was studied in CXXC1−/− ES cells expressing Y28A (1-656), D44A (1-656) and 
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W49A (1-656) by confocal immunofluorescence. Percent colocalization of H3K4me3 with 
DAPI-bright heterochromatin was significantly increased in CXXC1−/− ES cells and 
CXXC1−/− ES cells expressing vector compared to that in CXXC1+/+ ES cells or CXXC1−/− 
ES cells expressing CFP1 (1-656) as observed earlier [179]. However, a rescue of 
colocalization of H3K4me3 was observed in CXXC1−/− ES cells expressing Y28A (1-656), 
D44A (1-656) and W49A (1-656) (Figure 9A and 9B). These results suggest that the 
interaction of CFP1 PHD with methylated H3K4 is not essential for the rescue of 
appropriate targeting of H3K4me3 to euchromatin. 
 
e.  Interaction of CFP1 with methylated H3K4 or DNA is necessary for 
efficient differentiation of embryonic stem cells 
Pluripotent embryonic stem cells possess an ability to differentiate when cultured in 
suspension in a growth medium lacking LIF [204, 205]. The undifferentiated ES cells 
express high levels of alkaline phosphatase. Studies suggest that alkaline phosphatase can 
be utilized as a marker to quantitate the number of undifferentiated stem cells [206]. 
After the staining procedure, cells containing reddish deposits were considered positive 
for alkaline phosphatase activity. 
 
CXXC1−/− ES cells fail to differentiate in vitro when cultured in growth medium lacking 
LIF. This defect can be reversed by introduction of a full length CFP1 expression vector 
[177]. To determine if the interaction of CFP1 PHD with methylated H3K4 is important 
for the rescue of cellular differentiation, CXXC1−/− ES cells expressing W49A (1-656) 
were subjected to growth in ES medium lacking LIF for a period of 10 days. These cells 
produced embryoid bodies (EBs) and subsequently formed extensive outgrowths 
characteristic of endoderm formation almost identical to CXXC1+/+ ES cells and 
CXXC1−/− ES cells expressing full length CFP1 (1-656) cultured similarly (Figure 10). On 
staining these cells for alkaline phosphatase after a period of 10 days following LIF 
withdrawal, less than 5% of the cells were found to be positive for alkaline phosphatase 
(indicated by reddish deposits) suggesting that most of the CXXC1−/− ES cells expressing 
W49A (1-656) could undergo efficient differentiation (Figure 11). 
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Figure 9: Binding of CFP1 PHD to methylated H3K4 is dispensable for appropriate 
targeting of H3K4me3 to euchromatin in ES cells 
A) Sub-nuclear localization of endogenous H3K4me3 was detected in CXXC1+/+, 
CXXC1−/−, CXXC1−/− ES cells expressing vector, full-length CFP1 (1-656), or the 
indicated CFP1 mutations using a primary rabbit anti H3K4me3 antibody and bovine 
anti-rabbit IgG-fluorescein isothiocyanate (FITC)-conjugated secondary antibody. After 
counterstaining with DAPI, the nuclei were studied by confocal microscopy. Yellow 
regions in the merge and colocalized images indicate colocalization. The numbers within 
parentheses indicate the percent colocalization for that nucleus calculated using the 
MetaMorph colocalization module. The numbers not included within parentheses 
indicate the average percentage colocalization of H3K4me3 with DAPI bright 
heterochromatin and standard error for 7 to 37 nuclei. Asterisks represent statistically 
significant difference (p<0.05) compared to CXXC1+/+ ES cells. 
B) The results obtained in 9A are represented in the form of a bar graph. The error 
bars indicate standard error and asterisks denote statistically significant difference 
(p<0.05) 
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Figure 10: Interaction of CFP1 with H3K4me or DNA is necessary for formation of 
extensive outgrowths, characteristic of endoderm differentiation 
CXXC1+/+, CXXC1−/− and CXXC1−/− ES cells expressing vector, full length CFP1 (1-656), 
or the indicated mutations were grown in ES media lacking LIF for 10 days. Morphology 
of ES cell colonies was studied by microscopy ten days after induction of differentiation 
(10X magnification). 
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Figure 11: Interaction of CFP1 with H3K4me or DNA is necessary for down 
regulation of alkaline phosphatase activity during in vitro differentiation 
CXXC1+/+, CXXC1−/− and CXXC1−/− ES cells expressing vector, full length CFP1 (1-656), 
or the indicated mutations were grown in ES media lacking LIF for 10 days. After a 
period of 10 days, cells were collected from bacterial culture plates and trypsinized into a 
single cell suspension. These cells were re-seeded into tissue culture dishes coated with 
gelatin and were stained for alkaline phosphatase activity using a leukocyte alkaline 
phosphatase kit. Images were captured at 10X magnification. Cells containing reddish 
deposits were scored positive for alkaline phosphatase activity. A minimum of 300 cells 
were scored for each cell line. The numbers within the parentheses indicate the 
percentage of alkaline phosphatase-positive cells for the indicated cell line.
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Introduction of a DNA binding point mutation (C169A) or the SID domain mutant 
(C375A) in full length CFP1 completely rescues cellular differentiation suggesting that 
these domains are redundant for rescue activity [180]. To determine if similar 
redundancy existed amongst the PHD domain and the DNA binding domain, point 
mutations W49A and C169A in the respective domains were introduced into full length 
CFP1. Further, CXXC1−/− ES cells stably expressing W49A, C169A CFP1 (1-656) were 
induced to differentiate by removal of LIF. Ten days after the withdrawal of LIF, 
examination of morphology revealed that only a few EBs could adhere and form 
outgrowths that remained small over time. This observation was strikingly different as 
compared to the well-differentiated morphology of CXXC1+/+ ES cells, CXXC1−/− ES cells 
expressing full length CFP1 (1-656), W49A (1-656) or C169A (1-656). This suggests that 
CXXC1−/− ES cells expressing W49A, C169A CFP1 (1-656) are unable to undergo 
efficient differentiation (Figure 10). On staining for alkaline phosphatase, CXXC1+/+ ES 
cells, CXXC1−/− ES cells expressing full length CFP1 (1-656), W49A (1-656) and C169A 
(1-656) contained less than 5% alkaline phosphatase positive cells. However, in 
CXXC1−/− ES cells expressing W49A, C169A (1-656), approximately 41% of the cells 
were found to be positive for this marker, indicating an inability to undergo complete 
differentiation, consistent with our morphological findings (Figure 11). 
 
The process of ES cell differentiation entails a systematic and highly coordinated down 
regulation and up regulation of specific markers [207]. Oct4 is a master regulator of 
pluripotency of embryonic stem and germ cells [208]. Knockdown of Oct4 promotes 
differentiation of human and mouse ES cells [207, 209]. Induction of ES cell 
differentiation program results in down regulation of Oct4 expression. Previous studies 
indicate that CXXC1−/− ES cells are unable to down regulate mRNA expression of Oct4 
after induction of differentiation and this defect can be rescued by introduction of a full-
length CFP1 expression vector [177]. mRNA expression of Oct4 was determined by RT-
PCR for undifferentiated ES cells (Day 0) and 10 days after induction of differentiation by 
growth in the absence of LIF. The ratio of Oct4 mRNA expression to HPRT was used to 
evaluate the change in expression of Oct4 after 10 days of induction of differentiation. 
Parallel to our morphological observations, while CXXC1−/− ES cells and vector 
containing ES cells retained Oct4 expression at Day 10, CXXC1−/− ES cells expressing 
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W49A (1-656) could significantly down regulate Oct4 expression similar to CXXC1+/+ ES 
cells, CXXC1−/− ES cells expressing full length CFP1 (1-656) and C169A CFP1 (1-656) 
suggesting that these cells possess the ability to differentiate. On the other hand, Oct4 
mRNA levels fail to get sharply down regulated in CXXC1−/− cells expressing W49A, 
C169A CFP1 (1-656) suggestive of defective differentiation (Figure 12). 
 
WT but not CXXC1−/− ES cells, are able to upregulate lineage specific markers such as 
Gata-4 (endoderm), β-H1 (primitive erythroid), gp-IIb (megakaryocyte), c-fms (myeloid) 
and MHC-β (cardiac muscle) following differentiation by withdrawal of LIF [177]. On 
analyzing the mRNA expression of these lineage specific markers 10 days after removal of 
LIF, it was found that CXXC1+/+ ES cells, CXXC1−/− cells expressing full length CFP1 (1-
656), C169A (1-656), W49A (1-656) and W49A, C169A (1-656) possess the ability to 
activate markers of lineage restriction (Figure 12). 
 
These observations collectively suggest that interaction of CFP1 with methylated H3K4 is 
dispensable for efficient ES cell differentiation. However, the loss of interaction of CFP1 
with methylated H3K4 and DNA together by introducing a CFP1 PHD-H3K4me binding 
mutation (W49A) and a CFP1-DNA binding mutation (C169A) into CFP1 (1-656) results 
in an incomplete rescue of ES cell differentiation. 
 
Summary 
The data presented in this portion of the dissertation describes a direct and specific 
interaction of CFP1 with methylated H3K4 via its PHD domain. Transiently expressed 
Flag-tagged CFP1 was found to interact with endogenous H3K4me3 suggesting that this 
interaction occurs in vivo. Mutagenizing key residues necessary for binding (Y28, D44 
and W49) resulted in ablation of this interaction in vitro and in vivo. Experiments 
performed to understand the functional significance of this interaction reveal that 
CXXC1−/− ES cells expressing CFP1 point mutations that abolish interaction of CFP1 with 
H3K4me (W49A) can rescue targeting of H3K4me3 to euchromatin and in vitro 
differentiation. However, point mutations that abolish the interaction of CFP1 with 
methylated H3K4 and DNA result in defective in vitro differentiation. Although CXXC1−/− 
ES cells expressing CFP1 point mutations within the PHD and DNA binding domain, 
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express lineage specific markers, they fail to downregulate stem cell markers like alkaline 
phosphatase and Oct4, on induction of differentiation. 
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Figure 12: Interaction of CFP1 with H3K4me or DNA is necessary for down 
regulation of Oct 4 expression during in vitro differentiation 
CXXC1+/+, CXXC1−/− and CXXC1−/− ES cells expressing vector, full length CFP1 (1-656), 
or the indicated mutations were grown in ES media lacking LIF for 10 days. Collection of 
cells was done at Day 0 (undifferentiated) and Day 10 after growth in the absence of LIF. 
After isolation of total RNA, RT-PCR was performed for analyzing the expression levels of 
Oct 4 (a stem cell marker), HPRT (a constitutively active gene that was used as a control 
for RNA integrity and cDNA quantity), and lineage specific markers such as c-fms 
(myeloid), GpIIB (megakaryocyte), β-H1 (primitive erythroid), MHC- β (cardiac muscle) 
and GATA-4 (endoderm). 
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2. Characterization of the interaction between CFP1 and unmodified H3K4 
a. CFP1 PHD directly binds unmodified H3 
PHD domains present in AIRE, BHC80, UHRF1 recognize unmodified H3 (H3K4me0) 
with high specificity. [135, 136, 210] The conserved PHD finger consists of a two strand 
anti-parallel β sheet that is stabilized by two zinc atoms secured in its position by the 
Cys4-His-Cys3 motif in a cross brace topology [124, 125, 211]. The PHD domain in CFP1 
extends from amino acids 27-73. To understand the specificity of the association of CFP1 
PHD with the unmodified H3 tail, peptide pull-down assays were performed by 
incubating recombinant GST-CFP1 PHD (1-102aa) and biotin-labelled unmodified H3 
histone N-terminal tail peptide (1-21aa) followed by recovery of the histone 
peptide/GST-protein complex using streptavidin beads. Negative control reactions 
containing only GST-CFP1 PHD or only the unmodified H3 peptide were included to 
ensure that the observed interaction was a specific one. On western blotting the eluates 
using an anti-GST antibody, it was observed that GST-CFP1 PHD directly binds to 
unmodified H3 suggesting that CFP1 PHD functions as a reader of this mark (Figure 13). 
 
b. Binding affinity of CFP1 PHD to unmodified H3 is higher than that 
towards methylated H3K4 
In order to compare the binding affinity of CFP1 PHD towards H3K4me3, H3K9me3 and 
H3K4me0, competition histone peptide pulldown experiments were performed. GST-
CFP1 PHD was incubated with N-terminal, biotin labelled H3K4me3 peptide along with 
unlabeled H3K4me3, H3K9me3 and unmodified H3 as competitor peptides. This followed 
by the addition of streptavidin sepharose to immobilize the bound protein. It was found 
that an excess of unlabeled H3K9me3 did not affect the interaction between CFP1 PHD 
and H3k4me3. Thus, unlabeled H3K9me3 does not compete with biotin labelled 
H3K4me3 to interact with CFP1 PHD, suggesting that CFP1 PHD does not exhibit binding 
affinity towards the H3K9me3 tail peptide. However, it was found that a lesser amount of 
unlabeled H3K4me0 than unlabeled H3K4me3 peptide was required to compete with 
biotin labelled H3K4me3 interacting with CFP1 PHD. This suggests that CFP1 PHD binds 
with higher affinity to unmodified H3 than to H3K4me3 (Figure 14). 
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Figure 13: CFP1 PHD directly binds unmodified H3 
Histone peptide pulldowns were performed by incubating GST-CFP1 PHD with biotin-
labelled N-terminal (1-21aa) unmodified histone H3 peptide (H3K4me0) followed by 
addition of streptavidin sepharose beads. Bound proteins were analyzed by 
immunoblotting (IB) with GST antiserum. Pull down reactions containing only GST CFP1 
PHD or only the unmodified H3 peptide served as controls for specificity of interactions. 
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Figure 14: Binding affinity of CFP1 PHD to unmodified H3 is higher than that 
towards methylated H3K4 
Competition histone peptide pulldowns were performed by incubating GST-CFP1 PHD 
with biotin-labelled N-terminal (1-21aa) histone H3K4me3 peptide and an excess of the 
indicated unlabeled histone peptides (10 µg-25 µg) as competitors, followed by addition 
of streptavidin sepharose beads. Bound proteins were analyzed by immunoblotting (IB) 
with GST antiserum. 
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c. Mutations in CFP1 PHD do not ablate CFP1 PHD-unmodified H3 
interaction 
In order to determine the functional significance of the recognition of unmodified H3 by 
CFP1 PHD, site-directed mutagenesis was performed to introduce point mutations into 
CFP1 PHD (1-102) for various conserved residues as follows: 
i. Single mutations that ablate CFP1 PHD-H3K4me3 interaction Y28A, D44A, W49A: 
ii. Double and triple mutations for the above residues: (Y28A, W49A), (Y28A, 
D44A), (D44A, W49A), and (Y28A, D44A, W49A). 
iii. Single mutation, G42P that is thought to ablate hydrogen bonding between CFP1 
PHD and unmodified H3. Structural prediction was performed by Dr. Thomas 
Hurley, Indiana University School of Medicine, using PyMOL, a molecular 
visualization software used to view and compare 3D structures of proteins. 
iv. Single mutations of conserved cysteine residues: C29A, C73A 
v. Mutation of multiple conserved cysteine residues: 
I. (C29A, C73A) 
II. (C29A, C70A) 
III. (C29A, C43A, C46A) 
IV. (C29A, C43A, C46A, C73A)  
V. (C31A, C43A, C46A, C73A) 
vi. Mutation of a conserved histidine and multiple cysteine residues: 
VI.  (C29A, C43A, C46A, C73A, H51A, C54A) 
VII.  (C31A, C43A, C46A, C73A, H51A, C54A) 
vii. Mutation of conserved histidine and cysteine residues that define the signature 
Cys4-His-Cys3 motif:  
VIII.  (C29A, C43A, C46A, C70A, H51A, C54A, C73A) 
IX. (C31A, C43A, C46A, C70A, H51A, C54A, C73A)  
 
Addition of C70A mutation to the constructs prepared in (vi.) and subsequent histone 
peptide pulldowns for these two mutant proteins (vii.) were carried out by Ryan Eller, a 
rotation student from the Department of Biology, IUPUI. 
Residues indicated within parentheses () were mutated within the same construct. 
Roman numerals (I-IX) indicate the corresponding nomenclature used in figures. Histone 
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peptide pulldowns followed by western blots against GST were performed to examine the 
interaction of these mutant proteins with unmodified H3 tail peptide. Results from these 
experiments suggest that these mutations do not ablate the association of CFP1 PHD and 
unmodified H3 (Figure 15A and 15B). 
 
To examine if the binding between CFP1 PHD and unmodified H3 was actually mediated 
by direct contact and not indirectly by contaminating nucleic acids (RNA or DNA), 
leading to false-positive results, histone peptide pulldowns were performed after treating 
GST protein preparations with micrococcal nuclease (also referred to as S7 nuclease) 
[199]. Micrococcal nuclease cleaves single or double stranded DNA and RNA without any 
particular sequence specificity. WT GST-CFP1 PHD and the following mutant GST-CFP1 
PHD proteins were subjected to treatment with micrococcal nuclease and subsequently 
used for peptide pulldowns with unmodified H3. 
I. CFP1 PHD (C29A, C73A) 
VI. CFP1 PHD (C29A, C43A, C46A, H51A, C54A, C73A) 
VII. CFP1 PHD (C31A, C43A, C46A, H51A, C54A, C73A) 
 
These results suggest that interaction between mutant CFP1 PHD with unmodified H3 
remains unperturbed even after the treatment with micrococcal nuclease (Figure 16) 
thereby suggesting that this binding is not mediated by contaminating nucleic acids 
present in the GST protein preparation and can be expected to be a direct one. 
 
d. Analysis of various truncations of CFP1 PHD for unmodified H3 
binding 
In order to determine the stretch of amino acids in CFP1 PHD critical for interaction with 
unmodified H3, the following C- and N-terminal deletions of the domain were cloned into 
the pGEX-4T-1 vector.  
A. C-terminal deletions: 
i. CFP1 PHD (1-29) 
ii. CFP1 PHD (1-49)
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Figure 15: Mutations in CFP1 PHD do not ablate CFP1 PHD-unmodified H3 
interaction 
A) GST-CFP1 PHD (WT or the indicated mutants) were incubated with biotin-
labelled unmodified H3 peptide followed by pull down (PD) with streptavidin sepharose. 
Bound proteins were analyzed by immunoblotting (IB) with GST antiserum.  
YW: (Y28A, W49A) CFP1 PHD,  
YD: (Y28A, D44A) CFP1 PHD,  
DW: (D44A, W49A) CFP1 PHD,  
YDW: (Y28A, D44A, W49A) CFP1 PHD. 
B) Mutated GST-CFP1 PHD proteins (as indicated in the figure and below) were 
incubated with biotin-labelled unmodified H3 peptide followed by addition of 
streptavidin sepharose beads. Bound proteins were analyzed by immunoblotting (IB) with 
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GST antiserum. The Roman numeral indicated to the right of each pulldown represents 
the mutations in each of the GST-CFP1 PHD fusion proteins as follows: 
I. (C29A, C73A) CFP1 PHD 
II. (C29A, C70A) CFP1 PHD 
III. (C29A, C43A, C46A) CFP1 PHD 
IV. (C29A, C43A, C46A, C73A) CFP1 PHD 
V. (C31A, C43A, C46A, C73A) CFP1 PHD 
VI. (C29A, C43A, C46A, C73A, H51A, C54A) CFP1 PHD 
VII. (C31A, C43A, C46A, C73A, H51A, C54A) CFP1 PHD 
VIII. (C29A, C43A, C46A, C70A, H51A, C54A, C73A) CFP1 PHD 
IX. (C31A, C43A, C46A, C70A, H51A, C54A, C73A) CFP1 PHD 
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Figure 16: Binding of GST-CFP1 PHD is not mediated by contaminating DNA or RNA 
in GST-protein preparations 
WT and mutant GST-CFP1 PHD proteins (as indicated in the figure and below) were 
either treated (+) or not treated (-) with micrococcal nuclease (MNase) and further used 
to perform histone peptide pull down in the presence of biotin-labelled unmodified 
histone H3 tail peptide. Bound proteins were analyzed by immunoblotting (IB) with GST 
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antiserum. The Roman numeral indicated to the right of each pulldown represents the 
mutations in each of the GST-CFP1 PHD fusion proteins as follows: 
I.  (C29A, C73A) CFP1 PHD 
VI. (C29A, C43A, C46A, C73A, H51A, C54A) CFP1 PHD 
VII. (C31A, C43A, C46A, C73A, H51A, C54A) CFP1 PHD 
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iii. CFP1 PHD (1-73) 
B. N-terminal deletion: 
i. CFP1 PHD (50-102) 
 
This was followed by purification of truncated GST CFP1 PHD proteins and their use in 
histone peptide pulldowns with unmodified histone H3 tail peptide. This approach 
revealed that only the fragment constituting the complete PHD domain; CFP1 PHD (1-73) 
and not CFP1 PHD (1-29), CFP1 PHD (1-49) or CFP1 PHD (50-102) binds to unmodified 
H3. Hence, neither the N-terminal half; CFP1 PHD (1-49) nor the C-terminal half; CFP1 
PHD (50-102) is sufficient for CFP1 PHD-unmodified H3 binding activity (Figure 17) 
 
To further narrow down the amino acids critical for this binding event, following C-
terminal deletions were cloned into the pGEX-4T-1 vector. 
i. CFP1 PHD (1-55) 
ii. CFP1 PHD (1-60) 
iii. CFP1 PHD (1-65) 
iv. CFP1 PHD (1-70) 
 
Histone peptide pulldowns were performed using the above truncated CFP1 PHD protein 
fragments with unmodified histone H3 peptides. Results indicate that CFP1 PHD (1-55) 
shows diminished binding affinity to unmodified H3 whereas CFP1 PHD (1-60), CFP1 
PHD (1-65) and CFP1 PHD (1-70) can efficiently bind this mark (Figure 17). This 
suggests that residues 55-60 aa of CFP1 PHD may be important for binding. Hence, point 
mutations for charged residues that lie between amino acid 55 and 60 were introduced as 
follows; 
i. Single point mutations R56A, E59A, K60A 
ii. Triple mutations REK-AAA, REK-PPP, REK-GGG 
 
Simultaneously, a CFP1 PHD construct containing a deletion of amino acids 55-60 was 
made by site-directed mutagenesis (CFP1 PHD Del 55-60). Results from histone binding 
assays with unmodified H3 suggest that none out of the single point mutations R56A, 
E59A, K60A, the triple mutations REK-AAA, REK-PPP or CFP1 PHD Del 55-60 could 
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abolish the interaction between CFP1 PHD and unmodified H3 (Figure 18). Western blot 
analysis (Anti-GST) for CFP1 PHD containing REK-GGG mutation revealed that the 
protein resolved into multiple bands. This could be attributed to the increased flexibility 
imparted to the protein by replacement of charged residues to glycine, that might result 
in an unstable or a misfolded protein [212]. 
 
It is unclear if the drop in binding observed in REK-GGG is because of its instability. 
However, deletion of amino acids 55-60 (that includes R56, E59 and K60) did not ablate 
the binding of CFP1 PHD to unmodified H3. 
 
Summary 
The data presented in this part of the dissertation suggests that CFP1 PHD directly and 
specifically binds unmodified H3. Surprisingly, point mutation of several conserved 
residues did not result in ablation of the interaction between CFP1 PHD and unmodified 
H3. A summary of all the CFP1 PHD mutants/truncations analyzed for interaction with 
unmodified H3 is depicted in a tabular format (Table 6). 
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Figure 17: Analysis of various truncations of CFP1 PHD for unmodified H3 binding 
WT GST-CFP1 PHD or the indicated GST-CFP1 PHD truncations were incubated with 
biotin labelled N-terminal unmodified histone H3 tail peptide followed by addition of 
streptavidin sepharose beads. Bound proteins were analyzed by immunoblotting (IB) with 
GST antiserum. A schematic representation of the WT CFP1 PHD and its truncations are 
depicted in the above figure.
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Figure 18: Analysis of point mutations of charged residues located between amino 
acids 55-60 and their deletion in CFP1 PHD 
GST-CFP1 PHD proteins containing substitutions of charged residues located between 
amino acids 55 and 60 (as indicated in the figure) or showing a deletion of amino acids 
55-60 (Del 55-60) were incubated with biotin-labelled unmodified H3 peptide followed 
by addition of streptavidin sepharose beads. Bound proteins were analyzed by 
immunoblotting (IB) with GST antiserum. 
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Table 6: Summary of the binding activity of various CFP1 PHD mutations and 
truncations towards unmodified H3  
No. Point mutations within CFP1 PHD 
Interaction with 
H3K4me0 (+/-) 
1 Y28A (+) 
2 D44A (+) 
3 W49A (+) 
4 Y28A, W49A (+) 
5 Y28A, D44A (+) 
6 D44A, W49A (+) 
7 Y28A, D44A, W49A (+) 
8 G42P (+) 
9 C29A (+) 
10 C73A (+) 
11 C29A, C73A (+) 
12 C29A, C70A (+) 
13 C29A, C43A, C46A (+) 
14 C29A, C43A, C46A, C73A (+) 
15 C31A, C43A, C46A, C73A (+) 
16 C29A, C43A, C46A, C73A, H51A, C54A (+) 
17 C31A, C43A, C46A, C73A, H51A, C54A (+) 
18 C29A, C43A, C46A, C70A, H51A, C54A, C73A (+) 
19 C31A, C43A, C46A, C70A, H51A, C54A, C73A (+) 
20 R56A (+) 
21 E59A (+) 
22 K60A (+) 
23 REK-AAA (+) 
24 REK-PPP (+) 
25 REK-GGG (?) 
 Truncations of CFP1 PHD  
1 (1-29) (-) 
2 (1-49) (-) 
3 (50-102) (-) 
4 (1-73) (+) 
5 (1-55) Diminished 
6 (1-60) (+) 
7 (1-65) (+) 
8 (1-70) (+) 
9 DEL (55-60) (+) 
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The table represents a summary of the ability of various CFP1 PHD mutations and 
truncations to interact with unmodified H3. An ability to bind unmodified H3 is indicated 
by (+) whereas an inability to do so is indicated by (-). Further investigation is required 
to assess the ability of REK-GGG CFP1 PHD mutant to bind unmodified H3 (indicated by 
“?”).
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3. Delineation of the role of CFP1 in murine liver homeostasis and regeneration 
CFP1 is ubiquitously expressed in various tissues including liver [160]. CXXC1−/− 
blastocysts are unable to gastrulate and murine ES cells cannot differentiate in vitro in 
the absence of CFP1 [172, 177]. In order to study the significance of CFP1 in adult mice, 
our lab generated mice (C57BL/6) containing a conditional “floxed” CXXC1 allele 
(CXXC1fl/fl) which permits disruption of murine CXXC1 locus by exploiting the Cre-Lox 
system [176]. Induction of Cre recombinase by pI-pC in CXXC1fl/fl, Mx1 Cre+ mice 
resulted in deletion of the CXXC1 gene in the liver and hematopoietic cells of adult mice. 
However, no visible pathology was observed in the liver of these mice by the end of 13 
days when these mice die due to a severe defect in hematopoiesis [176]. It is unlikely 
that a function of CFP1 might manifest in the liver in this relatively short interval (13 
days), between depletion of CFP1 and death due to hematopoietic failure. 
 
To understand the role of CFP1 in long-term liver homeostasis and regeneration, a 
transgenic mouse line, carrying the conditional floxed CFP1 allele and the Cre 
recombinase gene under the control of the liver-specific albumin promoter (CXXC1fl/fl 
AlbCre+), was established. This mouse line permitted the depletion of CFP1 after the 
onset of expression of the albumin gene. 
 
a. Confirmation of CFP1 depletion specifically in the liver at the age of 5 
weeks 
The AlbCre transgenic mice [C57BL6-TgN(Alb-Cre)21Mgn] that were used in this 
studywere previously used in another study wherein the AlbCre transgene in combination 
with a floxed glucokinase gene allele resulted in deletion of this gene specifically in the 
liver. The authors reported that the efficiency of recombination was only ~40% at birth, 
75% at weaning (3 weeks) and appeared to be complete by 6 weeks of age even though 
albumin is expressed early during murine development (stage 7 to 8 somite). The authors 
suggest that this low level of recombination at birth might be because of a decreased 
expression of the Cre transgene [202]. Hence, experiments were performed to determine 
if deletion of CXXC1 in CXXC1+/fl AlbCre+ (heterozygotes) occurred at 5 or 10 weeks of 
age. Necropsies were performed for CXXC1+/fl AlbCre+ and control CXXC1+/fl AlbCre− 
mice and tissues from lung, liver, kidney and spleen were collected. Genomic DNA was 
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isolated from these tissues and semi-quantitative PCR was performed to amplify the 
recombined/disrupted allele and the conditional (floxed allele). Primers LOXP1F and 
LOXP3R were used to amplify the disrupted allele. The stretch of the CXXC1 gene 
between exon 2 and exon 14 is 4.2 kb long, thus making routine PCR amplification 
infeasible, resulting in the absence of a PCR product. However, following activation of 
Albumin Cre and disruption of the CXXC1 allele, exon 1 and exon 15 are only separated 
by a LoxP site, thus making routine PCR amplification possible and resulting in a PCR 
product. Therefore, formation of a PCR product in this reaction suggests deletion of 
CXXC1 gene (refer Figure 5A). On the other hand, primers LOXP1F and CXXC1R were 
used to amplify the conditional allele. The presence of a conditional allele that contains 
the LoxP site results in a band that is slightly larger than that produced from the wild 
type allele, resulting in the formation of a doublet band in mice that are heterozygous for 
the conditional allele. Results from these experiments indicate the presence of the 
recombined/disrupted CXXC1 allele specifically in the liver and not in other tissues such 
as lung, kidney and spleen as early as at 5 weeks of age. In parallel, a reduction in the 
conditional (floxed) allele, indicative of Cre recombination, was also observed only in the 
liver and was visible by 5 weeks of age. A reduction, and not a complete loss of the 
conditional allele might be because ~20% of the liver is composed of non-hepatocytic 
cells such as the macrophage Kupffer cells, stellate cells and endothelial cells [213]. 
These results together suggest that CXXC1 deletion occurs specifically in the liver within 
5 weeks of birth (Figure 19) (This experiment was performed with the help of Erika 
Dobrota). 
 
b. CFP1 protein expression is reduced in the livers of CXXC1fl/fl AlbCre+ 
mice  
To determine if CFP1 protein levels were affected in CXXC1fl/fl AlbCre+ mice compared to 
control CXXC1+/+ AlbCre+ mice whole cell extracts were prepared from liver tissues of 
these mice and western blotting was carried out using antiserum against CFP1. β- actin 
expression was used as the loading control. Results demonstrate that CFP1 protein 
expression is eliminated in CXXC1fl/fl AlbCre+ mice compared to that in CXXC1+/+ 
AlbCre+ mice (Figure 20) 
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Figure 19: Confirmation of CFP1 depletion specifically in the liver at the age of 5 
weeks 
Following necropsy, liver, lung, kidney and spleen tissues were collected from 5 and 10 
week old male CXXC1+/fl AlbCre+ and CXXC1+/fl AlbCre− mice. Genomic DNA isolated 
from these tissues was used in PCR reactions to (i) amplify the disrupted allele (top 
panels) using primers LOXP1F and LOXP3R and (ii) amplify the conditional allele (lower 
panels) using primers LOXP1F and CXXC1R (Refer figure 5A). One 5 week old CXXC1+/fl 
AlbCre− mouse (1), two 5 week old CXXC1+/fl AlbCre+ mice (2 and 3) and three 10 
week old CXXC1+/fl AlbCre+ mice (4, 5 and 6) were used for this experiment. As shown 
in the figure, the top band in the doublet in the lower panels indicated by “@”, 
corresponds to the conditional allele; whereas the lower band in the doublet, indicated by 
“#”, corresponds to the wild type allele
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Figure 20: CFP1 protein expression is reduced in the livers of CXXC1fl/fl AlbCre+ 
mice 
Whole cell extracts prepared from liver tissues of one CXXC1+/+AlbCre+ and four 
CXXC1fl/fl AlbCre+ mice (ages 4-44 weeks) were subjected to western blot analysis. The 
representative blot was probed for CFP1 and β-actin as a loading control
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c. Effects of CFP1 depletion in the mature, quiescent liver 
Loss of CFP1 had no effect on the viability of CXXC1fl/fl AlbCre+ mice. There was no 
marked difference in the litter size of CXXC1fl/fl AlbCre+ mice compared to CXXC1fl/fl 
AlbCre− mice. However, ~40% of CXXC1fl/fl AlbCre+ mice become sick and die after 
weaning at various ages (4-52 weeks) (Figure 21) These sick mice exhibit signs of a 
wasting phenotype: smaller size, lack of vitality and hunched posture (Figure 22). H&E 
staining of formalin-fixed, paraffin embedded tissue sections of their livers reveal 
extensive areas of degenerating hepatocytes that appear to be attempting to regenerate 
(irregular foci of very large hepatocytes with abundant eosinophilic cytoplasm). These 
foci were larger in older experimental animals (~70 weeks of age) imparting a gross 
nodular appearance to the liver (Figure 23). Liver sections from older experimental mice 
also often display areas of fibrosis. Recently, an independent group reported that a 
combined loss of EZH1 and EZH2 (enzyme subunits responsible for H3K27me3 marks) in 
mouse hepatocytes resulted in the development of regenerative nodules and fibrosis at 8 
months of age. This phenotype is very similar to that observed in CXXC1fl/fl AlbCre+ mice. 
Another observation was that the female CXXC1fl/fl AlbCre+ mice were unable to produce 
healthy and viable offspring. Eight breeding pairs consisting of female CXXC1fl/fl AlbCre+ 
and male CXXC1fl/fl AlbCre− mice were set up and monitored for a period of at least 6 
months. Of the 8 female mice, only one was found to become pregnant (enlarged 
abdomen), but was unable to carry the pups to term. This female mouse suffered from 
complications during parturition. Hence, no viable pups were obtained from this breeding 
scheme. 
 
CXXC1−/− ES cells exhibit increased (~40%) global H3K4me3 levels [161]. To examine if 
global H3K4me3 levels are altered in CXXC1fl/fl AlbCre+, histone proteins were extracted 
from liver tissues of these mice followed by western blot analysis for determining levels of 
global H3K4me3. It was found that there was a significant increase (~42%) in global 
H3K4me3 levels in CXXC1fl/fl AlbCre+ mice compared to CXXC1fl/fl AlbCre− mice, 
consistent with the observation in CXXC1-/- ES cells. (Figure 24A and B) 
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Figure 21: Loss of CFP1 results in premature death of CXXC1fl/fl AlbCre+ mice 
within one year 
Percentage of survival of CXXC1fl/fl AlbCre+ mice and CXXC1fl/fl AlbCre− mice over a 
period of 52 weeks (~1 year) was studied by generating Kaplan-Meier survival curves 
using the software GraphPad Prism 6. 
 
91 
 
Figure 22: Sick CXXC1fl/fl AlbCre+ mice display a “wasting” phenotype 
A photographic representation of the comparative sizes of a sick, moribund CXXC1fl/fl 
AlbCre+ and normal, healthy CXXC1+/+ AlbCre+ mouse. 
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Figure 23: Older CXXC1fl/fl AlbCre+ mice often show the presence of regenerative 
liver nodules 
Liver tissue collected from CXXC1fl/fl AlbCre+ and CXXC1fl/fl AlbCre− mice of the 
indicated ages were chemically fixed in 10% neutral buffered formalin, embedded in 
93 
paraffin and sectioned into 5 µm slides. These slides were subjected to the standard 
histopathological H&E staining to study the morphological characteristics of the liver 
tissue. Images were captured on a microscope at 10X magnification. Circles denote cells 
undergoing degeneration. The photograph on the bottom row shows the gross 
morphology of the liver excised from a representative 70 week old CXXC1fl/fl AlbCre+ 
mouse. 
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d. Effect of CFP1 depletion in the regenerating liver following partial 
hepatectomy 
Hepatocytes in the mammalian liver are mitotically quiescent, highly differentiated cells 
with a very long half-life. When the liver undergoes injury, the remnant healthy 
hepatocytes enter the cell cycle to rapidly compensate for the injury. To illustrate the 
effects of loss of CFP1 in the regenerating liver, a surgical procedure called partial 
hepatectomy was performed to remove 2/3 of the liver mass in experimental (CXXC1fl/fl 
AlbCre+) and control (CXXC1fl/fl AlbCre−) male mice. 
 
The gross liver sizes of the experimental and control mice appeared similar at the time of 
partial hepatectomy. These mice were sacrificed 7 days after surgery and the ratio of the 
mass of the remnant liver to total body mass was determined as a measure of 
regenerative response. Seven days after surgical resection, experimental mice aged 2-3 
months show a statistically significant ~26% reduction in liver mass compared to age-
matched control mice (Figure 25A). On the other hand, adult experimental mice aged 5-6 
months showed a severe reduction (~40%) in liver mass compared to their control 
counterparts (Figure 25B). To ensure that the reduction in liver mass is not affected by an 
overall loss in body mass that often occurs after surgical procedures, the remnant liver 
mass was reported relative to the mass of the right kidney. There was a significant 
reduction (~34%) in the ratio of liver to right kidney mass in adult experimental mice 
compared to control mice (Figure 25C). These results collectively suggest that 
regeneration of murine liver after partial hepatectomy is impaired in the absence of CFP1. 
 
Summary 
This section provides a detailed analysis of the importance of CFP1 in liver homeostasis 
and regeneration after partial hepatectomy. The mouse line (CXXC1fl/fl AlbCre+) lacking 
CFP1 specifically in the liver was established and characterized. Around 40% of these 
mice exhibit a wasting phenotype followed by death at various ages. Livers of these mice 
often show the presence of regenerative nodules at senescence. Additionally, CXXC1fl/fl 
AlbCre+ mice show an increase in global H3K4me3 levels. Furthermore, CXXC1fl/fl 
AlbCre+ mice show a blunted regenerative response post partial hepatectomy suggesting 
that CFP1 is important for the process of liver regeneration. 
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Figure 24: CXXC1fl/fl AlbCre+ mice show increased global H3K4me3 levels 
A) Male mice that were aged 5-6 months were used for this experiment. Histone 
proteins were extracted from liver tissues of four CXXC1fl/fl AlbCre− and five CXXC1fl/fl 
AlbCre+ mice by acid extraction. These histone proteins were subjected to western 
blotting analysis using H3K4me3 antiserum. The membrane was re-probed for total H3 as 
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a loading control. Representative western blot results for one animal of each genotype 
(CXXC1fl/fl AlbCre− and CXXC1fl/fl AlbCre+) are shown. 
B) The bar graph represents the quantitation of the average ± SE of H3K4me3 levels 
normalized to total H3 in CXXC1fl/fl AlbCre− (n=4) and CXXC1fl/fl AlbCre+ (n=5) mice. 
*p<0.05 represents a statistically significant difference compared to CXXC1fl/fl AlbCre− 
mice.
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Figure 25: CFP1 depletion results in an impaired regenerative response to partial 
hepatectomy 
A) Two to three month old CXXC1fl/fl AlbCre− (n=4) and CXXC1fl/fl AlbCre+ (n=3) 
mice were subjected to partial hepatectomy (surgical resection of 2/3 liver) and sacrificed 
seven days after surgery. Body mass and the mass of the remnant liver were noted. The 
bar graph represents the quantitation of the average ± SE of the remnant liver mass 
normalized to body mass in CXXC1fl/fl AlbCre− and CXXC1fl/fl AlbCre+ mice. **p<0.005 
represents a statistically significant difference compared to CXXC1fl/fl AlbCre− mice. 
B) Five to six month old CXXC1fl/fl AlbCre− (n=4) and CXXC1fl/fl AlbCre+ (n=5) 
mice were subjected to partial hepatectomy and sacrificed seven days after surgery. Body 
mass and the mass of the remnant liver were noted. The bar graph represents the 
quantitation of the average ± SE of the remnant liver mass normalized to body mass in 
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CXXC1fl/fl AlbCre− and CXXC1fl/fl AlbCre+ mice. ***p<0.0005 represents a statistically 
significant difference compared to CXXC1fl/fl AlbCre− mice. 
C) Five to six month old CXXC1fl/fl AlbCre− (n=4) and CXXC1fl/fl AlbCre+ (n=5) 
mice were subjected to partial hepatectomy and sacrificed seven days after surgery. Mass 
of the right kidney and the remnant liver were noted. The bar graph represents the 
quantitation of the average ± SE of the remnant liver mass normalized to mass of the 
right kidney in CXXC1fl/fl AlbCre− and CXXC1fl/fl AlbCre+ mice. ***p<0.0005 represents 
a statistically significant difference compared to CXXC1fl/fl AlbCre− mice.
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Discussion 
 
1. CFP1 binds to unmodified and methylated histone H3K4 via its PHD domain 
The studies presented in this part of the dissertation reveal that the N- terminal CFP1 
PHD domain interacts with unmodified H3 (H3K4me0) and methylated histone H3K4 
(H3K4me1/me2/me3).  The human CFP1 PHD domain, expressed as a fusion with GST 
in bacterial cells, was able to recognize both unmodified H3 and methylated H3K4 
histone tail peptides suggesting that these interactions were direct. Moreover, CFP1 PHD 
domain was unable to recognize H3K9me3, a heterochromatin marker, suggesting that 
this interaction was specific to the panel of histone-peptide tails examined in this work. 
Transiently expressed full length Flag-tagged CFP1, immunoprecipitated from the nuclear 
extract, binds to endogenous H3K4me3, suggesting that the interaction between CFP1 
and H3K4me3 occurs in vivo within the nuclei of cells. Thus CFP1, a component of the 
euchromatin-specific Set1 histone methyltransferase complexes that catalyze the 
deposition of H3K4me marks, is involved in interacting with the same mark. Moreover, it 
is possible that methylation of H3K9 results in the blocking of the binding of H3K4me3 to 
CFP1 and this could explain how a repressive mark (H3K9me) prevents CFP1 
recruitment. The loss of CFP1 results in a drop of H3K4me3 levels at CGIs and this defect 
is rescued by expression of full-length CFP1 [163, 181]. This suggests that CFP1 might 
participate in the reading of H3K4me marks and thereby facilitate a feedforward 
mechanism that aids the deposition of these marks at CGIs to maintain active chromatin 
status. Interestingly, many histone methyltransferase complexes adopt similar regulatory 
mechanisms for mediating activation or repression of specific genomic loci. For instance, 
WDR5, a common component of the MLL1, MLL2 and hSet1 complexes, functions as an 
effector protein by binding to H3K4-dimethylated nucleosomes and facilitating global and 
gene specific H3K4 trimethylation [214]. Another example is of HP1 that not only 
associates with H3K9me3 methyltransferase SUV39H1, but also recognizes the 
methylated H3K9 mark through its amino-terminal chromodomain. This phenomenon is 
thought to promote the establishment and spread of heterochromatin domains [215, 
216]. Pygo2, a developmentally important protein, consists of a PHD domain that 
specifically recognizes H3K4me2/3 and this interaction is critical to mammary progenitor 
cell expansion. Additionally, Pygo2 also facilitates the generation of these marks at Wnt-
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specific loci and in bulk chromatin thereby suggesting that a positive feedback loop might 
be in place for the establishment of active chromatin domains [130]. 
 
The residues corresponding to Y28, D44 and W49 of CFP1 PHD are conserved in many 
H3K4me3-binding proteins like BPTF, PHF2 and ING2 [125, 128, 131]. Of these, Y28 and 
W49 of CFP1 PHD correspond to Y10 and W32 of the BPTF PHD and are involved in 
formation of the aromatic amino acid cage that securely positions the trimethyl group of 
H3K4me3  [125]. Corresponding amino acids Y7/W29, present in PHF2 and Y215/W238, 
present in ING2 establish contacts with the trimethylammonium group of lysine 4 [131, 
217]. The point mutations Y28A, D44A and W49A in CFP1 PHD and full length CFP1 
resulted in ablation of their association with H3K4me3. This suggests that only the PHD 
domain of CFP1 is involved in binding to methylated H3K4. Moreover, it is also likely that 
the tri-methyl group of H3K4me3 is stabilized by aromatic residues Y28 and W49, similar 
to that in other known H3K4me3-binding proteins. 
 
PHD domains of proteins capable of binding unmodified H3, usually lack an aromatic 
cage [124]. It is also found that methylation of H3K4 disrupts the interaction of these 
PHDs with unmodified H3 [124, 218]. However, CFP1 PHD was found to interact with 
both the unmodified and methylated forms of H3K4 efficiently. It can be surmised that 
the binding of CFP1, to the substrate unmodified H3, aids the initial docking of the Set1 
enzyme complexes at the transcription start sites of active genes. This study revealed that 
point mutations of several conserved and charged amino acids were unable to abrogate 
the binding between CFP1 PHD and unmodified H3, suggesting that the amino acid 
residues critical for this binding activity might be other than the ones examined in this 
report. It might also be possible that point mutations within CFP1 PHD are unable to 
disrupt the overall tertiary structure of this domain to ablate its interaction with 
unmodified H3. The N- terminal half or the C-terminal half of CFP1 PHD is not sufficient 
to interact with unmodified H3, suggesting that this binding might be governed by the 
combinatorial participation of residues in both halves of the domain. Further 
investigation is required to identify a point mutation that ablates the interaction of CFP1 
PHD to unmodified H3. Therefore, the functional significance of the interaction of CFP1 
PHD with unmodified H3 still remains elusive. 
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2. Interaction of CFP1 PHD with methylated H3K4 is dispensable for 
appropriate H3K4me3 targeting 
CFP1 restricts the sub-nuclear localization of H3K4me3 to euchromatin [179]. This study 
examined the importance of the binding of CFP1 to methylated H3K4 for the regulation 
of the targeting of these marks to DAPI-dim euchromatin. The loss of the binding of CFP1 
to methylated H3K4 had no adverse effect on the targeting of H3K4me3 marks to 
euchromatin. However, it is possible that a CFP1 mutant that ablates binding to both 
unmodified H3 and methylated H3K4 will not be able to rescue appropriate genomic 
targeting of H3K4me3 to euchromatic regions. CFP1 regulates H3K4me3 levels at many 
CGI rich promoters of active genes [181]. It was also observed that the DNA binding 
function of CFP1 is not necessary for targeting of H3K4me3 to CGIs [181]. Therefore, it 
will be important to determine if the binding of CFP1 to unmodified H3 and/or to 
methylated H3K4 is required for the restoration of H3K4me3 levels at CGI rich 
promoters. 
 
Many reports have linked H3K4me3 levels at transcription start sites with another 
euchromatin specific mark, histone H3 acetylation (H3K9ac and H3K14ac) [219-221]. 
The Gcn5 subunit of the SAGA complex that catalyzes the acetylation of histone H3 
(H3K9ac, H3K14ac), can be targeted to the H3K4me3 nucleosomes via the adaptor 
subunit Sgf29 [21] [22] [222, 223]. Another group recently found that the lack of CFP1 
also results in a reduction in H3K9ac and H3K14ac, along with a reduction in H3K4me3 
levels at the transcription start sites of active genes in murine ES cells. [223]. It is 
possible that binding of CFP1 to unmodified and/or to methylated H3K4 is important for 
recruitment of Gcn5 to H3K4me3 nucleosomes to aid the accumulation of H3K9ac and 
H3K14ac marks at transcription start sites of active genes. 
 
3. Interaction of CFP1 with methylated H3K4 or DNA is required for efficient 
differentiation of ES cells 
This portion of the study explored the role of the interaction between CFP1 and 
H3K4me3 during the process of ES cell differentiation. Previous data indicates that either 
the DNA binding activity of CFP1 or interaction with the Set1 complexes is necessary for 
in vitro differentiation of ES cells, suggesting that the CXXC and SID domains of CFP1 are 
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redundant functional domains [180]. This study revealed that ablation of the interaction 
between CFP1 and methylated H3K4 does not adversely affect cellular differentiation. 
However, a combined disruption of both the H3K4me-binding and the DNA-binding 
activities of CFP1 resulted in compromised cellular differentiation. This suggests that 
neither the PHD nor the CXXC domains are required for in vitro differentiation and that 
the PHD and CXXC domains are redundant for this function. On induction of 
differentiation, embryoid bodies of CXXC1−/− ES cells expressing CFP1 containing point 
mutations in both PHD and CXXC domains fail to form extensive outgrowths and 
approximately 41% of these cells are unable to down regulate alkaline phosphatase (AP) 
activity. This indicates that approximately 41% of the ES cells containing mutated PHD 
and CXXC domains of CFP1 are unable to undergo lineage commitment. 
 
RNA isolated from embryoid bodies expressing mutant PHD and CXXC domains of CFP1 
was subjected to RT-PCR analysis of lineage and stem cell markers. When a population of 
mutant cells was examined, it was observed that markers of lineage commitment 
including c-fms, MHC-β and β-H1 were expressed along with the stem cell marker Oct4. 
Combined with the observations from the AP staining assay, it can be surmised that the 
~59% AP-negative cells are responsible for the up-regulation of lineage development 
markers and can down-regulate Oct4 simultaneously. However, the drop in the levels of 
Oct4 is not sharp presumably due to the remaining ~41% cells that might be unable to 
down-regulate Oct4 along with AP. Oct4 is a critical factor required to maintain the 
pluripotency and self-renewal properties of murine ES cells [224]. Down regulation of 
Oct4 is essential for in vivo and in vitro differentiation of ES cells into the three germ 
layers; endoderm, ectoderm and mesoderm [225]. Persistence of Oct4 expression after 
induction of differentiation suggests that that the self-renewal capacity of ~41% of the 
mutant ES cell population remains unaffected and that this fraction of the population is 
unable to efficiently execute the differentiation program. One of the mechanisms of 
down-regulation of Oct4 during the process of differentiation requires the methylation of 
Oct4 promoter [226]. It is possible that the inability of CXXC1−/− ES cells expressing 
W49A, C169A CFP1 (1-656) to achieve in vitro differentiation is influenced by the 
defective methylation status of the Oct4 promoter. 
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The observation reported in this study that only a portion of the population of CXXC1−/− 
ES expressing W49A, C169A (1-656) remains undifferentiated 10 days after induction of 
differentiation could also be because of a delay in the differentiation program. A similar 
delay in differentiation is observed in the absence of Tcf3 in murine ES cells [227]. Tcf 
proteins are DNA binding transcriptional regulators that participate in the Wnt signaling 
pathway. Tcf3 is the most abundant Tcf factor in ESCs and the loss of Tcf3 by genetic 
ablation in ESCs results in a delay in differentiation without affecting their self-renewing 
properties. The authors found that, while Tcf3+/+ ES cells expressed lineage specific 
markers including GATA4 and GATA6 as early as 3 days after induction of differentiation 
and retained their expression throughout the duration of the assay (8 days), Tcf3−/− ES 
cells, on the other hand, expressed low levels of lineage-specific markers even after 8 
days of differentiation. Additionally, levels of a stem cell marker LRH-1 were down 
regulated in Tcf3+/+ ES cells, but remained fairly persistent in Tcf3−/− ES cells after 8 
days of differentiation. However, this did not prevent differentiated Tcf3−/− cell types 
from occurring during in vitro differentiation [227]. This defect was found to be due to 
the deregulation of the Tcf3’s repressor activity on the Nanog promoter. Similarly, it is 
possible that the down-regulation of stem cell markers including Oct4 and AP is delayed 
in ES cells expressing PHD and CXXC domain mutations. Therefore, the ability of CFP1 to 
interact with methylated H3K4 and DNA might be required for the repression of other 
key genes governing cell fate following the induction of cellular differentiation. 
 
Previous data revealed that either the N-terminal half (1-367aa) or the C-terminal half 
(361-656 aa) of CFP1 is sufficient for the rescue of in vitro differentiation in CXXC1−/− ES 
cells. However, the data reported in this dissertation suggests that either the PHD domain 
or the CXXC domain is required to rescue defective ES cell differentiation. Both of these 
domains are present in the N-terminal half of CFP1. The fact that the C-terminal half of 
CFP1 (not containing PHD or CXXC domain) completely rescues cellular differentiation 
could be possibly due to folding differences in truncated proteins resulting in differential 
exposure of key epitopes as compared to full length proteins. Another possibility could be 
that the C-terminal half of CFP1 lacks an uncharacterized ‘inhibitory’ domain that could 
inhibit the rescue of various functions. 
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The differentiation defect of the CXXC1−/− ES cells expressing W49A, C169A (1-656) is 
subtle as compared to the defect observed in CXXC1−/− ES cells. It is possible that the 
ability of the mutant CFP1 protein to rescue some pleiotropic mechanisms involved in the 
process of differentiation, is because of the presence of intact acidic, basic, SID, coiled-
coil and HEAT domains of CFP1. 
 
It could be argued that the differentiation defect observed in approximately 41% of the 
CXXC1−/− ES cells expressing W49A, C169A (1-656) (persistent AP activity) might be 
because of cellular variation in the levels of CFP1 protein. However, this is unlikely 
because stable ES cell clones resistant to hygromycin were individually isolated and 
expanded. Another possibility for the presence of a mixture of AP positive and AP 
negative cells upon differentiation could be because of the architecture of the embryoid 
bodies. Cells that form the exterior of the embryoid body are epithelial-like and display 
cell-cell tight junctions and form a dense layer of extra cellular matrix along with cells at 
the periphery as compared to the interior of the embryoid body [228]. It is possible that 
intact CFP1 PHD and CXXC domains are required differentially for regulating the interior 
and exterior microenvironment of embryoid bodies. 
 
4. The histone binding property of CFP1 might be important for the resolution 
of bivalent promoters into active promoters upon ES cell differentiation 
In mammalian cells, genomic domains are marked by distinct histone modifications. For 
example, H3K4me3 and H3K9/H3K27me3 are primarily found on active and repressed 
promoters respectively whereas active enhancers are marked by H3K4me1 and H3K27ac 
[229]. However, pluripotent embryonic stem cells contain a large group of gene 
promoters that display a co-occurrence of both activating (H3K4me3) and repressing 
(H3K27me3) marks [155, 230]. These bivalent domains are thought to maintain 
developmentally important genes in the “poised state”, enabling their rapid activation on 
receiving suitable developmental signals. These bivalent domains track with the 
unmethylated CpG islands that form a part of ~70% of all promoters in ES cells [7, 230]. 
CFP1 consists of a CXXC domain that specifically binds unmethylated CpGs [162]. Recent 
studies indicate that loss of CFP1 adversely affects H3K4me3 levels on the promoters of 
actively transcribed genes; however H3K4me3 levels on bivalent promoters are less 
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affected [181, 231].  This may suggest that recruitment of MLL1/2 might be more 
prevalent in these domains. 
 
MLL2 consists of a CXXC domain that interacts with unmethylated CpGs [232]. There is 
evidence that the MLL2 enzymes mediate H3K4 trimethylation on bivalent gene 
promoters [233]. On induction of differentiation, most bivalent promoters lose one of the 
marks (H3K4me3 or H3K27me3), resulting in activation or repression of specific genes. 
However, the loss of MLL2 did not affect retinoic acid induced gene expression of 
bivalent promoters [233]. Thus, it is possible that the existing H3K4me3 marks on 
bivalent promoters bind CFP1 PHD and recruit the Set1 complex and result in a 
feedforward mechanism for deposition of more H3K4me3 marks thereby playing an 
active role in resolving bivalent promoters into active gene promoters enriched with 
H3K4me3 marks. 
 
5. The proper targeting of Set1/H3K4me3 at gene promoters is regulated by 
many mechanisms 
Appropriate targeting of the Set1 complex is thought to be coordinated by a number of 
mechanisms. Set1 complexes consist of two components Wdr82 and CFP1 that are 
lacking in the other COMPASS like complexes (MLL1-4) [63, 64, 161]. Wdr82 interacts 
with the C-terminal domain (CTD) of RNA polymerase II and recruits the Set1 complex to 
the transcriptional start sites of active genes [65]. Moreover, RNAi-mediated knockdown 
of Wdr82 results in a global reduction of H3K4 trimethylation with almost no effect on 
mono/di-methylation levels of H3K4, suggesting that Wdr82 is critical for H3K4 
trimethylation [63]. Further, monoubiquitination of histone H2B has been found to be 
required for association of the yeast analog of Wdr82 (Cps35) to chromatin and the 
subsequent trimethylation of H3K4 [38]. Another study revealed that the Paf1 complex 
physically associates with the yeast Set1/COMPASS complex and recruits the COMPASS 
complex to the elongating form of RNA polymerase II [86]. 
 
The catalytic Set1A and Set1B proteins exhibit an overall sequence identity of 39% and a 
similarity of 56%. However, these proteins consist of an extensive central region that 
exhibits only 29% sequence identity and 41% similarity. Moreover, Set1a and Set1b are 
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found to have non-overlapping distributions within euchromatin regions as observed by 
confocal immunofluorescence [64]. Therefore, it can be expected that the central 
divergent domains of Set1A and Set1B confer distinct and non-redundant genomic 
targeting properties to these enzyme complexes thereby contributing to the complex 
nature of Set1 genomic targeting. 
 
CGIs consisting of unmethylated CpGs have been shown to bind the CXXC domain of 
CFP1 and recruit the Set1 complexes to these loci for the deposition of H3K4me3. 
Artificial exogenous CpG rich insertions are sufficient for this targeting function [163]. 
Deletion of CFP1 in mouse ESCs results in the depletion of H3K4me3 from the CGI-rich 
promoters of actively transcribed genes with the simultaneous appearance of ectopic 
H3K4me3 at many regulatory regions. Expression of a CFP1 mutant lacking DNA binding 
activity results in the rescue of H3K4me3 levels at promoters but does not prevent 
aberrant H3K4me3 accumulation at the distal regulatory elements, suggesting that the 
DNA binding function of CFP1 is not required for the targeting of Set1 to the promoter 
regions [181]. The domain of CFP1 that mediates the targeting function still remains 
unidentified. The work done in this part of the dissertation suggests that CFP1 exhibits 
binding specificity to both the unmodified and the methylated form of H3K4. It is possible 
that CFP1 recruits the Set1 complex to its substrate unmodified H3 and facilitates the 
deposition of H3K4me3 marks at the promoter regions. Binding of CFP1 to 
H3K4me1/me2/me3, the product of the Set1-mediated methylation may additionally be 
required for targeting of the Set1 complex to active promoters having low levels of 
H3K4me3 in the absence of CFP1 [181]. It is therefore apparent that the molecular 
mechanisms involved in Set1 targeting are convoluted and further investigation is 
required to fully appreciate these complexities. 
 
6. CFP1 is required for the appropriate epigenetic control of liver homeostasis 
This portion of the study examined the role of CFP1 in murine liver homeostasis and 
regeneration. This involved the generation of a transgenic mouse line lacking CFP1 
specifically in the liver. These mice carried the conditional (floxed) allele for the CXXC1 
gene and the Cre-recombinase gene under the control of the liver-specific albumin gene 
promoter. Expression of albumin begins early (stage 7 to 8 somites) in murine 
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development [202, 234]. However, when the AlbCre transgene was used in combination 
with the conditional glucokinase gene allele, efficiency of recombination was found to be 
progressive with age, appearing to be complete by 6 weeks of age [202]. Previous 
research has indicated that the fetal liver is primarily a hematopoietic organ with a small 
population of hepatocytes [235]. However, at the perinatal stages of gestation, the 
function of hematopoiesis is undertaken by the bone marrow and majority of the liver is 
populated by hepatocytes, thus conferring hepatic functions to the liver [236]. Use of a 
marker that converts from red to green fluorescence following Cre-recombination 
revealed that the progressive increase in the efficiency of Cre-recombination is due to a 
progressive reduction in the proportion of non-hepatocytic cells in the liver, coupled with 
an increase in hepatocyte population [237]. This suggests that the AlbCre transgene is a 
useful tool for probing the functions of genes at various stages of liver development. 
Examination of AlbCre mediated recombination of the conditional CXXC1 allele revealed 
that deletion of the CXXC1 gene occurred at five weeks of age. Additionally, CFP1 protein 
levels were markedly reduced by the age of 4-5 weeks. 
 
As observed in CXXC1−/− ES cells, global H3K4me3 levels in the mutant livers were 
significantly higher. This suggests that the loss of CFP1 results in aberrant activation 
and/or targeting of H3K4 methylases. It is also possible that the Set1/H3K4me3 targeting 
defect observed in CXXC1−/− ES cells [179] is also reflected in mutant livers lacking 
CFP1. 
 
CFP1 physically interacts with DNMT1 and facilitates global cytosine methylation [168].  
ES cells lacking CFP1 show reduced global cytosine methylation levels [177]. However, 
following depletion of CFP1, differentiated hematopoietic cells in adult mice do not show 
a decline in global cytosine methylation levels [176]. Hence, although adult livers lacking 
CFP1 were not examined for global cytosine methylation defects in this study, it is 
surmised that these livers may not display a defect in global cytosine methylation levels. 
 
Around 40% of the mutant mice succumbed to a “wasting” phenotype within a year in 
the absence of liver CFP1. HNF4 α is a protein important for the morphological and 
functional differentiation of hepatocytes [238]. Depletion of HNF4α in the murine liver 
108 
resulted in an overall loss of body weight followed by death of ~70% of the mutant mice 
by 8 weeks of age [239]. The wasting phenotype associated with mice lacking liver CFP1, 
although subtle, is similar to that observed in mice lacking HNF4α in the liver. It possible 
that CFP1 and HNF4α interact to facilitate appropriate expression of genes required for 
liver homeostasis. Alternatively, lack of CFP1 might result in the down regulation of 
HNF4α expression, thus resulting in a wasting phenotype similar to that observed in 
HNF4α-depleted mice. Another possibility is that the loss of CFP1 results in epigenomic 
stress due to altered histone modifications, resulting in deregulation of liver homeostasis. 
Moreover, assessment of H&E stained liver sections of mutant mice often revealed large 
areas of hepatocytes undergoing apoptosis and degeneration. These hepatocytes have 
eosinophilic cytoplasm suggesting that they are prone to degenerate (communicated by 
Dr. HogenEsch). ES cells lacking CFP1 also undergo increased apoptosis and exhibit 
decreased global protein translation [178, 180]. Although the exact molecular 
mechanism for this phenomenon is not clear, the increased apoptosis could be attributed 
to the global translation defect [178] that might result in aberrant expression of pro-
apoptotic proteins (Bad, Bak, Bid, Bax) or anti apoptotic proteins (Bcl-2 or Bcl Xl) in 
livers lacking CFP1. 
 
The livers from older mutant mice lacking CFP1 formed regenerative nodules. A similar 
phenotype of the development of regenerative nodules has been reported in mice lacking 
EZH1 and EZH2 (enzymes catalyzing deposition of H3K27me3), suggesting that histone 
lysine methyltransferases play an important role in the maintenance of liver homeostasis 
[198]. 
 
Previous studies in the lab have elucidated the role of CFP1 in developmentally important 
cellular processes such as gastrulation and hematopoiesis [172, 173, 176]. However, this 
is the first study that suggests the participation of CFP1 in the maintenance of tissue 
homeostasis in an adult animal. This is supported by the fact that CFP1 is ubiquitously 
expressed in mature tissues [240]. However, at the same time, the role of CFP1 in the 
epigenetic regulation of tissue homeostasis is also intriguing because mature tissues do 
not undergo active chromatin remodeling like that occurring during the process of 
embryonic development. 
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7. CFP1 is critical for the process of murine liver regeneration 
Liver regeneration is a highly coordinated process that entails ~95% of terminally 
differentiated hepatocytes to re-enter the cell cycle and reach peak DNA synthesis at 36 
hours. Restoration of liver mass occurs after 1-2 rounds of cell divisions within the next 5-
7 days. Genome-wide expression analysis in many cell lines have revealed that the 
promoters of most cell cycle-related genes are enriched with unmethylated CpGs and the 
active chromatin mark H3K4me3 [241]. It is possible that CFP1 binds to the 
unmethylated CpGs at these sites thereby recruiting the Set1 complex. Thus, epigenetic 
regulation might be critical for the process of liver regeneration. This study shows that 
CFP1-depleted livers fail to fully compensate the loss of liver mass suffered during partial 
hepatectomy. This suggests that CFP1 is important for the proper control of liver 
regeneration. Although our experimental design did not include a no surgery or sham 
surgery control group of age-matched male mice, the gross liver sizes of the experimental 
and control mice appeared similar before parial hepatectomy. The H3K27 
methyltransferases, EZH1 and EZH2 are also known to play a crucial role in liver 
regeneration. Loss of EZH1/2 impairs regenerative response to liver injury due to partial 
hepatectomy and CCl4 treatment [198]. It will be interesting to delineate the possible 
crosstalk between H3K4-and H3K27-methylases that might be a prerequisite for 
establishing proper epigenetic control required for liver regeneration. 
 
There is very little known about the role played by various chromatin modifying enzymes 
in the epigenetic regulation of liver regeneration. This is the first study to our knowledge 
that illustrates the role played by a component of a H3K4-methylase in the regulation of 
liver regeneration. Further investigation is required to clearly elucidate the molecular 
mechanisms involved in this regulatory process. The knowledge of the molecular bases of 
liver regeneration in rodents can be extended to understand this process in humans to 
delineate the pathologies in which liver regeneration is impaired and ultimately provide 
new treatment options for patients suffering from liver damage. Nevertheless, this study 
provides preliminary information about the critical role played by CFP1 and the Set1 
complexes in liver regeneration. 
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Future Directions 
 
This dissertation focusses on understanding the role of CFP1 in two distinct systems. The 
first part examines the importance of the histone binding function of CFP1 PHD for 
appropriate targeting of H3K4me3 and during the process of in vitro differentiation in 
murine ES cells. The second part delineates the significance of CFP1 in liver homeostasis 
and regeneration. Further investigation is required for a clearer understanding of these 
functions of CFP1. 
 
In vitro binding assays indicated that CFP1 PHD interacts with unmodified H3, although 
the inability to find point mutations that would ablate binding of CFP1 PHD to 
unmodified H3 prevented us from assessing the functional role of this interaction. In 
order to precisely determine the molecular basis of the read-out of unmodified H3 by the 
CFP1 PHD finger, crystal structures of CFP1 PHD in the free-state and in complex with H3 
(1-21aa) can be determined. The crystals of the CFP1 PHD-unmodified H3 complex can 
be grown using the hanging drop vapor diffusion method. The crystals obtained can be 
analyzed for their diffraction properties [217]. This can provide information about the 
residues of CFP1 PHD and the unmodified histone H3 tail that make contacts with each 
other, thereby allowing subsequent mutagenesis for studying the functional significance 
of this binding event. 
 
The mechanism and affinity of the binding of CFP1 PHD to unmodified H3 can 
additionally or alternatively be studied by isothermal titration calorimetry. Isothermal 
titration calorimetry can provide information about the number of peptide binding sites 
in CFP1 PHD and this might be important to generate a CFP1 mutant that is devoid of 
histone binding properties. Calorimetric experiments can be conducted using MCS-ITC 
instrument from MicroCal. The CFP1 PHD finger and lyophilized unmodified H3 peptides 
dialyzed in the same dialysis buffer can be used for titration [125, 217]. 
 
After identification of critical residues for binding unmodified H3 and understanding the 
binding mechanism, using the above techniques, point mutations of the critical residues 
can be generated by site-directed mutagenesis. These point mutations, most likely, can 
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also be expected to ablate binding with methylated H3K4. Subsequently, stable CXXC1-/- 
ES cells expressing mutant CFP1 (mutCFP1) can be isolated. These stable clones can 
further be used to understand the role of CFP1-histone binding function for the 
regulation of H3K4me3 levels at the transcription start sites of actively transcribed genes. 
Chromatin immunoprecipitation (ChIP) followed by qPCR can be performed to assess the 
levels of H3K4me3 at the transcription start sites of constitutively active genes such as 
Actb, Gapdh and Rpl3. Additionally, ChIP-qPCR can be performed to examine the levels 
of Set1 and CFP1 at the promoter regions of selected active genes. Further, analysis of 
genome-wide Set1 and H3K4me3 distribution in ES cells expressing mutCFP1 can be 
carried out by ChIP coupled to massively parallel DNA sequencing. Moreover, CXXC1-/- ES 
cells expressing mutCFP1 (mutant that is unable to bind histones) may exhibit a wide 
variety of defects in the rescue of functions including cytosine methylation, histone 
methylation, in vitro differentiation, DNA damage sensitivity, population doubling time 
and plating efficiency. These experiments collectively can provide a thorough 
understanding of the functional significance of CFP1-histone interaction. 
 
It is currently unknown if loss of interaction of CFP1 with methylated H3K4 [W49A CFP1 
(1-656)] or loss of interaction of CFP1 with methylated H3K4 and DNA together [W49A, 
C169A CFP1 (1-656)] affects the genome-wide levels of CFP1, Set1 and H3K4me3. 
Expression of C169A CFP1 in CXXC1−/− ES cells resulted in rescue of H3K4me3 levels at 
active promoters, but retained the inappropriate accumulation of H3K4me3 at regulatory 
regions outside CGIs [181]. This suggests that CXXC1−/− ES cells expressing W49A, 
C169A CFP1 may also display the defect of ectopic H3K4me3 accumulation apart from 
other defects that may be observed due to ablation of CFP1-H3K4me binding. Previous 
data indicates that the various mutations and truncations of CFP1 that do not rescue 
histone methylation and cytosine methylation levels are also unable to rescue in vitro 
differentiation of ES cells [180]. Based on this, it may be expected that CXXC1−/− ES cells 
expressing W49A, C169A CFP1 (1-656) might have aberrant histone and cytosine 
methylation levels. However, the extent of this aberration may be lower because a 
majority of the cells were able to undergo lineage commitment. 
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Ablation of binding of CFP1 to methylated H3K4 or DNA did not affect the rescue of in 
vitro cellular differentiation in ES cells. However, ablation of both these binding activities 
together resulted in compromised cellular differentiation. It is yet to be determined if 
ablation of binding of CFP1 to methylated H3K4 (W49A) and Set1 (C375A) affects the 
differentiation potential of ES cells. To understand this, site-directed mutagenesis can be 
performed to introduce the point mutations W49A and C375A into CFP1 (1-656). 
Further, this mutated form of CFP1 can be stably expressed in CXXC1−/− ES cells 
followed by induction of differentiation by growth in ES media lacking LIF. ChIP-qPCR 
followed by ChIP-Seq can be also be performed to assess the genome-wide levels of CFP1, 
Set1 and H3K4me3 in these mutant cells. 
 
The second part of this dissertation examines the role of CFP1 in murine liver 
homeostasis and regeneration. There are many unexplored avenues to further the current 
level of understanding of this newly established role of CFP1. This study evaluated the 
effect of depletion of CFP1 in liver regeneration at the end of 7 days when the restoration 
of the lost liver mass is expected to be completed in the murine liver [186]. However, the 
defects in liver regeneration observed in the absence of CFP1 can be examined in more 
detail by performing a time-course study. Age matched, male CXXC1fl/fl AlbCre+ 
(experimental) and CXXC1fl/fl AlbCre− (control) mice undergoing partial hepatectomy or 
sham surgery can be sacrificed at 1, 2, 3 and 7 days following surgery. Blood can be 
drawn from the heart under isofluorane anesthesia [198]. Liver and body mass can be 
determined after euthanasia followed by preparation of formalin-fixed, paraffin 
embedded liver sections. The effect of the loss of CFP1 on liver integrity and function can 
be assessed by examining the levels of serum markers such as alanine aminotransferase 
(ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), and albumin; both 
in mature, quiescent and regenerating livers lacking CFP1 at various ages. Increase in 
serum levels of ALT and AST is a sensitive indicator of altered hepatocyte integrity 
whereas an increase in ALP levels signifies biliary obstruction. Furthermore, elevated 
serum albumin levels indicate an overall impairment of liver function [198]. 
 
Adult liver tissue consists of quiescent cells that remain in the G0 phase of the cell cycle. 
Upon liver regeneration following liver injury, these quiescent cells enter the cell cycle to 
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replenish the mass of the lost liver. The extent of proliferation of hepatocytes in the 
regenerating liver can be assessed by staining liver sections for Ki-67, a cellular marker of 
proliferation and appearance of mitotic figures. 
 
It is yet to be determined if mRNA and protein expression of CFP1 is up/down regulated 
in wild type regenerating livers during the process of liver regeneration. Quantification 
and localization of CFP1 mRNA can be assessed by in situ hybridization (RNA ISH) on 
liver tissue sections whereas protein levels of CFP1 can be determined by western blotting 
using antiserum against CFP1. Additionally, examination of global levels of histone H3K4 
and cytosine methylation in the regenerating liver can provide insight into the epigenetic 
dysregulation occurring in the absence of CFP1. 
 
A genome-wide perspective of the alteration of H3K4me3 and DNA cytosine methylation 
marks can be achieved by performing high throughput ChIP-Seq on the hepatocytes 
derived from the experimental and control mice using antibodies against H3K4me3, 5-
methyl cytosine or IgG control. Viable, primary hepatocytes can be isolated using a 
collagenase digestion method [242] followed by crosslinking with 1% formaldehyde for 
10 min. Chromatin obtained from these hepatocytes can be sonicated to 200-300 bp. 
Further, the immunoprecipitated DNA can be blunt ended and ligated to Illumina 
indexed DNA adaptors (Illumina Inc, San Diego, CA) and sequenced using the Illumina 
HiSeq 2000 followed by downstream bioinformatic data analysis. This approach can 
provide valuable information regarding the aberrations found in the overall distribution 
of H3K4me3 and 5-methyl cytosine marks in the CFP1-deficient livers. 
 
Additionally, RNA-sequencing (RNA-Seq) can be performed for a comparative analysis of 
the liver transcriptomes of the experimental and control mice. Briefly, following the 
isolation of total RNA from liver tissues of the experimental and control mice, cDNA can 
be synthesized using the Superscript (Invitrogen) and TruSeq RNA sample preparation kit 
(Illumina). This cDNA can be sequenced using HiSeq 2000 (Illumina). This experiment 
will provide information about the possible differences in gene expression patterns 
between the experimental and control livers. In combination with the ChIP-seq 
experiment describe earlier, it can be assessed if the genome-wide distribution of 
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H3K4me3 and 5-methylcytosine marks correlate with the gene expression patterns 
observed in CFP1-depleted livers. These studies will eventually be useful to identify key 
genes that undergo genetic and epigenetic modulation during liver homeostasis and/or 
regeneration. Furthermore, these high throughput experiments can also provide clues 
about the possible epigenetic cross talk mechanisms that may be required for supporting 
liver homeostasis and regeneration. 
 
A small cohort of older experimental mice displayed fibrosis of liver tissue. To assess the 
extent of fibrosis, Masson’s trichrome staining for collagen can be performed. 
Examination of the CFP1-deficient liver transcriptome can reveal the up-regulation of 
genes associated with fibrosis. 
 
Carbon tetrachloride (CCl4)-induced liver injury is another widely used model for 
investigation of liver regeneration. Unlike the surgical process of partial hepatectomy, this 
mode of damage can be easily induced by 4 sub-cutaneous injections of CCl4 (2ml/kg, 2 
times a week) [198]. The difference in the rate of proliferation of hepatocytes between 
experimental and control mice can be ascertained by Ki-67 staining at various time 
intervals. It is likely that CFP1-deficient mice will be unable to undergo compensatory 
regeneration and survive the CCl4 mediated toxicity. 
 
The mammalian pancreatic tissue also possesses partial regenerative properties. Acinar 
cells, the most abundant pancreatic cell type, are the exocrine cells that produce and 
transport enzymes that assist with digestion of food and are capable of regeneration 
following pancreatectomy. Epigenetic mechanisms governing acinar cell regeneration are 
largely under-studied.  The importance of CFP1 for acinar cell regeneration can be 
assessed by generating a mouse line lacking CFP1 in acinar cells by breeding CXXC1fl/fl 
mice with ElastaseCreERT2 mice. The ElastaseCreERT2 mice express Cre recombinase 
(Cre) as a fusion with a mutant estrogen receptor ligand-binding domain (ERT2) that is 
selectively responsive to tamoxifen [243]. The expression of CreERT2 is under the control 
of the strong and highly acinar cell specific elastase I promoter [243]. This will enable the 
deletion of CFP1 specifically in the acinar cell compartment. Acinar cells are known to 
undergo transdifferentiation into insulin-secreting β-cells in vitro [244]. A better 
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understanding of the epigenetic control mediated by CFP1 in acinar cell regeneration can 
be of immense value to further the utilization of these cells as surrogate insulin-secreting 
β-cells for the treatment of Type 1 diabetes. 
 
The liver of the pregnant mouse undergoes dramatic changes during pregnancy. A two 
fold increase in liver weight is observed from the non-pregnant state to day 18 of 
pregnancy [193]. The features of liver growth occurring during pregnancy overlap with 
those observed during liver regeneration after partial hepatectomy [193]. In this study, it 
was observed that female CXXC1fl/fl AlbCre+ mice were unable to produce healthy and 
viable offspring.  It is possible that lack of CFP1 results in the impairment of maternal 
liver growth occurring during pregnancy, thus resulting in abortions. This phenomenon 
can be studied in detail by setting up timed pregnancies in these mice. Both ovulation 
and mating typically occur during estrus, which occur after the onset of the dark cycle 
(absence of visible light) and lasts for 12-14 hours. Female mice can be housed in large 
groups in the absence of male mice in the vicinity. This results in the prolongation of 
diestrus and suppression of estrus due to the absence of male urinary pheromones 
(Whitten effect). Once the female mice are housed with male CXXC1fl/fl AlbCre− mice, 
estrous cycle will resume within 3 days. Vaginal plugs can be examined the following 
morning to check if mating has occurred. If the plugged female mouse becomes pregnant, 
the day after the plug is found is considered as the first day of gestation [245]. The 
pregnant female CXXC1fl/fl AlbCre+ mice can be euthanized at various stages of 
pregnancy to evaluate the change in liver mass and to identify the stage of pregnancy 
when abortions occurred. These experiments can potentially uncover additional roles that 
CFP1 might play in the regulation of liver growth during pregnancy. 
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Summary 
 
The data presented in this dissertation describes the histone binding properties of the 
epigenetic regulator CFP1. It was observed that CFP1 directly binds to methylated H3K4 
via its PHD finger. Results suggest that the interaction of CFP1 PHD with methylated 
H3K4 is not required for appropriate subnuclear localization of endogenous H3K4me3 
and for the ability of ES cells to differentiate in vitro. However, studies revealed that 
introduction of a point mutation (C169A) that ablates the binding of CFP1 with DNA and 
a point mutation (W49A) that ablates binding of CFP1 with methylated H3K4 results in 
compromised cellular differentiation. These results indicate that the retention of either 
the CXXC or PHD domain is sufficient for the rescue of in vitro differentiation of ES cells, 
suggesting that these domains are redundant for this function. Moreover, CFP1 PHD also 
binds directly to unmodified H3. In order to study the functional significance of this 
interaction, point mutations for several conserved and charged amino acids were 
introduced into CFP1 PHD, however, binding of CFP1 PHD to unmodified H3 remained 
unaffected. 
 
This dissertation also examines the importance of CFP1 in regulation of homeostasis in 
the quiescent adult murine liver. To this end, a mouse line was developed that carried the 
conditional (floxed) allele of CXXC1 and the Cre-recombinase gene under the control of 
the liver specific albumin promoter. The activation of Cre-recombinase resulted in 
depletion of CFP1 specifically in the liver by the age of 5 weeks. This model was used to 
study the role of CFP1 in long-term liver tissue homeostasis and regulation of 
regenerative response. Studies revealed that ~40% of the population of CFP1-deficient 
mice succumbed to a wasting phenotype within a year. Also, livers of CFP1-deficient mice 
often developed regenerative nodules and displayed altered global H3K4me3 levels. To 
understand the role of CFP1 in the process of liver regeneration, CFP1-deficient mice 
were subjected to partial hepatectomy. Comparison of the residual liver masses 7 days 
after the procedure revealed a severe impairment of compensatory liver growth in CFP1-
deficient mice. This suggests that CFP1 is involved in the epigenetic regulation of liver 
regeneration. A clear understanding of the role of CFP1 in the molecular control of liver 
regeneration may prove useful for delineating pathologies involving impairment of liver 
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regeneration and ultimately provide new and better options for therapeutic intervention 
for patients with liver damage. 
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